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ABBREVIATIONS 
ATP adenosine triphosphate 
BK channels large-conductance calcium-sensitive and voltage-
dependent potassium channels 
  
CaM calmodulin 
cAMP cyclic adenosine monophosphate 
cGMP cyclic guanosine monophosphate 
CICR Ca2+-induced Ca2+ release 
  
DAG diacylglycerol 
  
IBTX iberiotoxin 
IC internal circumference 
IP3 inositol 1,4,5 -trisphosphate 
  
KCa channels calcium-activated potassium channels 
Kv channels voltage-dependent potassium channels 
KIR channels inward rectifier potassium channels 
KATP channels ATP-sensitive potassium channels 
  
MLCK myosin light chain kinase 
MRs myogenic responses 
  
PD pore-loop domain 
PKA protein kinase A (cAMP-dependent protein kinase) 
PKC protein kinase C 
PKG protein kinase G (cGMP-dependent protein kinase) 
  
qPCR real-time quantitative polymerase chain reaction 
technique 
  
RCK Ca2+-sensing domain that regulate the conductance 
of K+  of BK channles 
RyRs ryanodine receptors 
  
SM smooth muscle 
SR sarcoplasmic reticulum 
STOCs spontaneous transient outward currents 
STTX stromatoxin-1 
  
VDCCs voltage-dependent Ca2+ channels 
Vm membrane potential 
VSD voltage sensor domain 
VSM vascular smooth muscle 
VSMCs vascular smooth muscle cells 
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1 INTRODUCTION 
The cardiovascular system is an organ system comprising three basic parts: heart, 
blood and vessels, in which the heart as a pump, blood as a carrier and vessels as 
elastic tubes, are integrated to transport oxygen, hormones, nutrients etc. to tissues 
of the body and take waste away from them. Disorders happening in any part of them 
would impair the health of the body and even threaten life.  
Among them, vessels play an essential role in determination of blood pressure and 
regulation of blood distribution to different organs and tissues in order to meet the 
demand of the body in different environments. As known, except capillaries, the wall 
of vessels consists of three distinct layers: tunica intima, tunica media and tunica 
externa, where endothelial cells are located in the intima and smooth muscle cells in 
the media. Collagen fibers are the major part of the externa, and elastic fibers exist 
between each tunica (Fig.1.1).  
The contractility of vascular smooth muscle cells (VSMCs) at the media creates 
vascular tone as a key element of vessel function that determines the diameter of 
vessels and hence creates the resistance to blood flow. 
 
1.1 Ion channels in vascular smooth muscle 
Like all smooth muscles (SM), the contractile activity of vascular smooth muscle 
(VSM) is triggered by the increased intracelluar Ca2+. When Ca2+ binds to calmodulin 
(CaM), this Ca2+-CaM complex activates myosin light chain kinase (MLCK), which 
facilitates phosphorylation of myosin. The phosphorylated myosin sequentially 
attaches to and slides along actin, forming ‘cross bridges’, by which the muscle fibers 
shorten and vascular tone is increased (Fig 1.2)(Brozovich et al., 2016).. 
In VSMCs, the major source of activator Ca2+ is influx from the extracelluar space 
through voltage-dependent Ca2+ channels (VDCCs) whose activity is plasma 
membrane potential determined. As the activity of ion channels expressed within the 
plasma membrane of VSMCs is the major determinant of the membrane potential, 
ion channels play a central role in the maintenance of vessel contractile function. 
Consequently, a number of physiological modulators or stimuli in the circulatory 
Figure 1.1 Structure of an artery wall 
(Blausen.com staff, 2014) 
The wall of an artery from the innermost layer 
to the outermost layer can be divided into 
tunica intima, tunica media and tunica 
externa. 
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system, such as neurotransmitters, hormones, endothelium-derived factors and blood 
pressure itself, can via regulation of the activities of ion channels to mediate 
membrane potential, alter the entry of Ca2+ into VSM and hence regulate vascular 
tone (Knot and Nelson, 1998). 
  
Figure 1.2 Membrane potential in the regulation of arterial smooth muscle tone 
There are four major types of ion channels expressed in plasma membranes of VSMCs, which are nonselective 
cation channels, chloride (Cl
-
) selective channels, voltage-dependent Ca
2+ 
channels (VDCCs) and potassium (K
+
) 
channels. Their activities determine VSM membrane potential to mediate the entry of Ca
2+
 into VSMCs and hence 
regulate vascular tension. When the membrane depolarization happened: 1) Intracellular Ca
2+
 concentration 
increased with Ca
2+
 influx via VDCCs and some Ca
2+ 
released from the sarcoplasmic reticulum (SR). 2) Ca
2+
 
binds to calmodulin (CaM). 3) Ca
2+
-CaM activates myosin light chain kinase (MLCK). 4) MLCK phosphorylates 
light chains at myosin heads and increases myosin ATPase activity. 5) Active myosin cross bridges slide along 
actin and create VSM tension.  Vm, membrane potential 
It has been demonstrated that there are four major types of ion channels expressed 
in plasma membranes of VSMCs: (i) non-selective cation channels including store-
operated Ca2+ channels and stretch-activated cation channels, (ii) Cl- selective 
channels, (iii) voltage-dependent Ca2+ channels, and (iv) K+ channels. Nonselective 
cation channels and Cl- selective channels contribute to the depolarization of the 
membrane potential leading to activation of VDCCs to provide Ca2+ entry for VSM 
contraction, while K+ channels counteract these vasoconstrictions through facilitation 
of membrane hyperpolarization and limitation of membrane depolarization resulting in 
a reduced entry of extracellular Ca2+ (Fig 1.2). All these channels may be involved in 
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the regulation of vascular tone, especially K+ channels (Jackson 2000; Thorneloe and 
Nelson 2005). 
1.2 Potassium channels 
As the major hyperpolarizing ion conductive pathway in VSMCs, potassium channels 
play a central role in the determination of the membrane potential and in the 
regulation of vascular tone. It has been established that abnormal expression, 
downregulation, or dysfunction of potassium channels are involved in the 
pathogenesis of many cardiovascular pathological conditions: hypotension, 
excessive vasoconstriction or vasospasm, hypertension as well as ischemia (Nelson 
and Quayle 1995; Jackson 2000; Thorneloe and Nelson 2005).  
There are four major types of potassium channels identified in VSMCs: 
1) Voltage-dependent potassium (Kv) channels are activated by membrane 
depolarization. 
2) Large-conductance calcium-sensitive and voltage-dependent potassium (BK, 
MaxiK, Slo1, KCa1.1) channels are one subfamily of calcium-activated potassium 
(KCa) channels characterized by large conductance for potassium ions (250-
300pS in symmetrical 150mM KCl) that is 10-20 times greater than the classical 
voltage-activated K+ channels. They respond to changes in membrane potential 
and intracellular Ca2+ (Lang and Ritchie, 1990; Pallotta et al., 1981). 
3) Inward rectifier potassium (KIR) channels respond to changes in extracellular K
+ 
to regulate the resting membrane potential in small resistance vessels (Bradley et 
al., 1999; Quayle et al., 1997). 
4) ATP-sensitive potassium (KATP) channels are activated by cytoplasmic ATP 
depletion to sense the metabolic state of VSM. 
 
Among them, Kv and BK channels are most ubiquitously expressed in VSM, and they 
have been attracting increasing attention to investigate their specific roles as 
negative feedback regulators in the regulation of vascular tension and the 
Figure 1.3 Negative feedback 
mechanisms of potassium channels 
in VSM contraction 
With membrane depolarization, amounts 
of Ca
2+ 
influx through VDCCs, which not 
only induce VSM contraction, but also 
evoke Ca
2+
 transiently released from 
sarcoplasmic reticulum (SR) through 
RyR and IP3R. At this time, voltage-
dependent (Kv) activated by 
depolarization and large-conductance, 
Ca
2+
-sensitive, voltage-dependent (BK) 
channels activated by depolarization as 
well as increased Ca
2+
 provide a 
hyperpolarization conductance, thereby 
braking depolarization-mediated VSM 
contraction by inhibition of  Ca
2+
 entry 
through VDCCs.  
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possibilities of regulation of their function for treatment of relevant vascular diseases 
(Fig 1.3). 
1.3 Kv7 (KCNQ) channels 
To date, 12 subfamilies of Kv channels (Kv1– Kv12) have been identified (Wulff et al., 
2009). Among them, Kv7 channels (Kv7.1–Kv7.5) encoded by the KCNQ (KCNQ1–5) 
genes have emerged as a spotlight in VSM research in the recent ten years. 
Originally, KCNQ channels were thought to be distributed strictly in particular tissues 
with distinct functions (Robbins, 2001), such as KCNQ1 discovered in cardiac 
myocytes contributing to action potential repolarization, KCNQ2, KCNQ3 and KCNQ5 
detected in the nervous system contributing to the M-current and the resting potential 
of neurons, and KCNQ4 in inner ear hair cells relating to the resting membrane 
potential and the submembrane Ca2+ concentration. However, in recent years, an 
increasing number of reports indicated that KCNQ channels are not only expressed 
in various VSMCs, but also fulfill an important role in the regulation of contractile and 
relaxant functions of arteries. Moreover, they might become a novel therapeutic 
target for the treatment of disorders of the vascular system (Ohya et al., 2003; Yeung 
et al., 2007). 
Structurally, like other Kv channels, Kv7 channels are a complex assembled by four 
pore-forming α-subunits encoded by KCNQ genes. Each α-subunit contains six trans-
membrane spanning domains (S1–S6) with cytoplasmic NH2- and COOH-terminal 
regions. The S1-S4 regions form the voltage sensor domain (VSD) where S4 
contains positively charged amino acids (arginines) as voltage-sensing elements. A 
single K+-selective pore-loop domain (PD) electromechanically coupled to the VSD is 
located between the S5 and S6 regions. At the COOH-terminal region, α subunits 
can interact with accessory proteins, e.g., β-subunits encoded by KCNE 1-5 genes, 
to modulate the biophysical properties of Kv7 channels (Fig 1.4) ( Pongs et al. 1999; 
Bähring et al. 2001; Robbins, 2001; Thorneloe et al. 2001; Korovkina and England, 
2002; Pongs and Schwarz 2010; Soldovieri et al., 2011).  
 
Functionally, Kv7 channels are directly activated by membrane depolarization. The 
activation threshold is relatively negative at approximately -60 mV. When membrane 
depolarization stimulated the VSD into the active state, the VSD can attach to the PD 
and converts the electrical energy in the membrane into mechanical force to alter the 
conformation of the K+ selective pore from the closed to the open state (González et 
Figure 1.4 Schematic structure of 
Kv channel α-subunits 
The Kv channel α subunit consists of 
six transmembrane spanning 
domains (S1–S6) with cytoplasmic 
NH2- and COOH- terminal segments, 
S1-S4 is the voltage sensor domain 
(VSD) with positively charged 
arginines in S4, and the single K
+
-
selective pore-loop domain (PD) is 
located between S5 and S6. 
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al. 2012; Stott et al. 2014). As soon as the Kv7 channels open, the increased K+ 
efflux driven by the K+ ions electrochemical gradient promotes hyperpolarization of 
the plasma membrane. Thus, Kv7 channels provide an important K+ conductance for 
the maintenance of the membrane potential of VSMCs in the physiological range (-
40mV~ -70mV), to limit membrane depolarization, brake the activation of VDCCs, 
and hence maintain vascular tone(Sperelakis and Ohya, 1989; Nelson and Quayle 
1995; Stott et al. 2014). Notably, an agonist-induced increase of intracellular Ca2+ 
following membrane depolarization has been reported to inhibit Kv channel activity 
(Tykocki et al., 2017), but the molecular mechanism of this interaction is unclear. 
Several selective Kv7 channel-specific pharmacological agents have been developed 
and became very effective tools to investigate and determine the specific functions of 
Kv7 channels in various organs. Specifically, XE991 and linopirdine selectively inhibit 
Kv7 channels and increase vascular tone, while retigabine and flupirtine can 
selectively activate Kv7 channels except homomeric KCNQ1 and lead to the 
relaxation of preconstricted arteries (Tatulian et al., 2001; Joshi et al. 2009; Ng et al. 
2011; Morales-Cano et al. 2015).  
In addition, some studies indicate that Kv7 channels act as effectors for some 
vasodilators and vasoconstrictors. Thus, Kv7 channels can be activated by cyclic 
AMP (cAMP)-dependent vasodilators (e.g., isoproterenol) and cyclic GMP (cGMP)-
dependent vasodilators (e.g., sodium nitroprusside), whereas vasoconstrictors (e.g., 
vasopressin) might inhibit Kv7 channels by PKC activation (Stott et al., 2014, 2015).  
1.4 BK channels 
The BK channel, one of the most ubiquitously expressed channels in various VSMCs, 
has been investigated intensively in the recent three decades (Nelson and Quayle 
1995; Ko et al. 2008). Because of its high expression level and large single channel 
conductance, BK channels are one of the central determinants in the regulation of 
the plasma membrane potential (Nelson and Quayle 1995; Jackson 2005).  
The structure of BK channels is similar to Kv7 channels (Fig 1.5). It is also a tetramer 
of pore-forming α-subunits accompanied with tissue specific regulatory β subunits. 
The α-subunits, encoded by a single gene (KCNMA1), confer the voltage-dependent 
and Ca2+-sensitive abilities of the BK channel. Each α-subunit is composed of seven 
trans-membrane spanning domains (S0–S6) with an extracellular NH2-terminal 
segment and a large cytoplasmic COOH-terminal tail (Wallner et al., 1996). Likewise, 
the voltage sensor domain (VSD) of BK channels is formed by S1-S4 where the S4 
region also contains positively charged arginines. The S5–S6 domain forms the K+ 
selectivity pore-loop domain (PD). The S0 domain with an extracellular NH2-terminal 
segment can directly interact with the VSD as well as with regulator β-subunits. The 
COOH-terminal tail is sensitive to intracellular Ca2+, and is thought to include two 
tandem Ca2+-sensing domains that regulate the conductance of K+ (RCK): RCK1 and 
RCK2. These two RCK domains include at least three Ca2+ binding sites: the first 
high-affinity Ca2+ site is the voltage independent Ca2+ bowl located in RCK2 which 
functions at  low Ca2+ concentrations; the second high-affinity Ca2+ site stays at the 
upstream RCK1, is voltage dependent and modulates channel activity during both 
activation and deactivation at Ca2+ concentrations higher than 10 μmol/L; a third 
lower affinity divalent cation sensing domain in the RCK1 is able to bind Mg2+ and 
Ca2+ to affect VSD function (Schreiber and Salkoff 1997; Toro et al., 1998; Wu and 
Marx, 2010; González et al. 2012). The biophysical properties of the BK channel, 
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especially its Ca2+ sensitivity, can be modified and enhanced by association with β-
subunits that consist of two transmembrane spanning domains leaving an 
intracellular NH2- segment and COOH-terminal tail. There are four isofoms of β-
subunits encoded by the KCNMB1–4 genes (Uebele et al. 2000; Brenner et al. 2000; 
Cox and Aldrich 2000). Among them, β1 is abundant in VSMCs( Jiang et al. 1999; 
Sausbier et al. 2005; Brenner et al. 2000). Besides β-subunits, γ-subunits are also 
detected to affect BK channel regulation (Zhang and Yan, 2014).  
 
 
 
The BK channel is activated synergistically by membrane depolarization and the 
increased intracellular localized Ca2+. Generally, when the Ca2+ entry through VDCCs 
stimulates Ryanodine receptors (RyRs) on the SR, Ca2+-induced Ca2+ release (CICR) 
events can be initiated, in which Ca2+ is released from the SR in the form of Ca2+ 
sparks; meanwhile, Ca2+ is also released in the form of puffs from SR when IP3 
receptors on the SR are activated by Ca2+ influx through VDCCs (Jaggar et al., 2000). 
With these transient localized Ca2+ released from the SR as well as with some of the 
Ca2+ entering the cells via VDCCs, binding to the RCK on the BK channel decreases 
the necessary energy required to open the BK channel by shifting the voltage-
dependent activation to negative voltages, so that the BK channel can be opened 
within a physiological range of membrane potentials and generate spontaneous 
transient outward currents (STOCs) ( Cox and Aldrich 2000; Perez et al., 2001; Hill et 
al. 2010; Hu and Zhang 2012). Therefore, the activity of BK channels is fundamental 
for the control of vascular tone by discouraging membrane depolarization and braking 
further Ca2+ entry through VDCCs (Klockner and Isenberg 1985; Brayden and Nelson 
1992; Nelson and Quayle 1995; Guia et al. 1999; Herrera and Nelson 2002). 
Meanwhile, BK channels also provide a bridge between the ionic metabolism of the 
cell and plasma membrane conductance with its ability to sense changes both in 
membrane potential and in the intracellular Ca2+ concentration. 
BK channel selective agents, either activators or blockers, are both useful tools for 
the exploration of the particular roles of the BK channel. In VSM, BK channels can be 
blocked by external tetraethylammonium (TEA, half-inhibition concentration ~200 µM), 
charybdotoxin (~10 nM) or iberiotoxin (IBTX, <10 nM) leading to membrane potential 
depolarization and vasoconstriction. Among them, IBTX is the most selective blocker 
Figure 1.5 Schematic structure of BK 
channel α and β subunits 
(Zhang and Yan, 2014), modified 
The BK channel α subunit consists of 
seven transmembrane spanning domains 
(S0–S6) with extracellular NH2- and 
cytoplasmic COOH-terminal segments, 
S1-S4 is the voltage sensor domain 
(VSD) with positively charged arginines in 
S4, and the single K
+
-selective pore-loop 
domain (PD)  is  located between S5 and 
S6; 
Accessory β-subunit associate with BK 
channels, which is composed of two 
transmembrane spanning domains 
leaving intracellular NH2- and COOH- 
terminal segments. 
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(Galvez et al. 1990; Nelson and Quayle, 1995). However, till now, regarding BK 
channel activators, although several candidates have emerged, there is no confirmed 
agent with high selectivity for the BK channel. In 2014, B. Nausch with his colleagues 
proposed that NS19504 is a positive modulator of BK channels in urinary bladder SM 
(Nausch et al., 2014), but there is no report describing how NS19504 acts on VSM. In 
this study, NS19504, as a promising candidate, was tested. 
Similar to Kv7 channels, cAMP-dependent and cGMP-dependent vasodilators might 
also activate the BK channel through PKA and PKG, respectively. Conversely, 
vasoconstrictors might inhibit BK channels by PKC activation (Ko et al., 2008).  
1.5 Questions and aims 
1) The role of Kv7 and BK channels in the contractility of skeletal muscle arteries 
To date, most investigations on the role of Kv7 channels or BK channels in pressure-
induced constrictions were performed on cerebral arteries, while in agonist-induced 
contractions it was preferred to employ mesenteric arteries. There are only a few 
studies to show the expression and function of Kv7 or BK channels in skeletal muscle 
arteries.  
Thus, in this study we examined Kv7 and BK channels in two skeletal muscle arteries: 
the Saphenous artery (A. Saphena), a conduit artery responsible for the blood supply 
to the skeletal muscles of rat hind limb, and the Gracilis artery (A. Gracilis), a 
resistance artery responsible for the blood supply to Gracilis muscle (M. gracilis) on 
the rat hind limb. The role of Kv7 and BK channels in the contractility of A. saphena 
and A. Gracilis was studied by methoxamine-induced contractions in wire myograph 
experiment and by pressure-induced myogenic responses in pressure myograph 
experiments, respectively. 
2) The interaction between Kv7 channels and BK channels 
As far as we know, although there are an increasing number of investigations 
focusing on the function of Kv7 channels or BK channels in VSM, there is no report to 
describe and clarify whether there is functional interaction between both of them.  
As mentioned above, Kv7 channels are voltage-dependent, while BK channels are 
voltage-dependent as well as calcium-sensitive. Both of them can respectively 
maintain vascular tone through limiting membrane depolarization and regulating Ca2+ 
entry. Theoretically, Kv7 channels could alter the membrane potential and Ca2+ influx 
through VDCCs and thereby affect the activity of BK channels. In turn, BK channels 
also can regulate the activity of Kv7 channels by inducing changes in membrane 
potential. For example, inhibition of Kv7 channel activity leads to membrane potential 
depolarization. This depolarization may activate BK channels directly as well as 
indirectly by the subsequent increase of intracellular Ca2+ via the depolarization-
induced opening of VDCCs. On the other hand, inhibition of BK channels also leads 
to membrane potential depolarization that may directly activate Kv7 channels, but 
with depolarization, the subsequent increase of intracellular Ca2+ might contribute to 
a deactivation of Kv7 channels, in which the joint effect of activation and deactivation 
is unclear (Fig 1.6).  
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Figure 1.6 Flow diagram of the proposed roles of Kv7 and BK channels 
(Nelson & Quayle 1995), modified 
Therefore, theoretically an interaction between Kv7 and BK channels exists, but 
experimental supporting evidence is lacking. In this study, selective activators and 
blockers of Kv7 and BK channels were employed to examine the hypothesis that 
there is functional interaction between Kv7 and BK channels under normal 
physiological conditions, which contributes to the maintenance of skeletal muscle 
arterial contractility.  
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2 MATERIAL AND METHODS 
2.1 Matertials 
2.1.1 Animals 
Wistar rats (male, 8-12 weeks old) were decapitated after carbon dioxide (CO2) 
anesthetization. The experimental design was approved by the local authority 
responsible for animal experimentation. All experimental procedures were performed 
in accordance with the Guide for the Care and Use of Laboratory Animals published 
by the US National Institutes of Health (Eighth edition, National Academy of 
Sciences, 2011). 
2.1.2 Arteries 
The gracilis artery (A. Gracilis, resistance artery) and the saphenous artery (A. 
Saphena, conduit artery) both located on the rat hind limb were used to perform the 
investigation of the present study (Fig. 2.1). 
 
2.1.3 Reagents 
In myograph experiments:  
Name Catalogue No. Manufacturer 
CaCl2*2H2O A862982 824 Merck 
D(+)-Glucose 455236245 Carl Roth 
EDTA  485234480 Carl Roth 
EGTA 465235141 Carl Roth 
HEPES A1069,1000 Applichem 
KCl 475237252 Carl Roth 
Figure 2.1 Vessel anatomy of the 
rat left hind limb after removal of 
the skin 
The label A. Gracilis represents the 
Gracilis artery that is one branch of 
the femoral artery; 
The label A. Saphena represents the 
Saphenous artery that arises from 
the femoral artery 
Both of them are accompanied by 
their corresponding veins (V.) and 
nerves, respectively. 
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MgSO4*7H2O  A0478986321 411   Merck 
NaCl  486252534 Carl Roth 
NaH2PO4*H2O  A0314746 131 Merck 
NaHCO3  K45372729 421 Merck 
   
Acetylcholine chloride A6625-25G Sigma-Aldrich 
DPO-1 2533 Tocris Bioscience 
HMR1556 5011 Tocris Bioscience 
Iberiotoxin STI-400 Alomone Labs 
Methoxamine hydrochlorid  M6524-500MG Sigma-Aldrich 
NS19504  5276 Tocris Bioscience 
Retigabine Lot. 0005005 Valeant research and development 
Stromatoxin-1 STS-350 Alomone Labs 
XE991 dihydrochloride 2000 Tocris Bioscience 
 
- Specific function of essential reagents  
Name Function 
XE 991 potent and selective Kv7 channel blocker 
Retigabine Kv7 channel activator, especially for Kv7.2-Kv7.5 
Iberiotoxin (IBTX) selective and reversible BK channel blocker 
NS19504 BK channel activator 
HMR1556 potent and selective Kv7.1 channel blocker 
DPO-1 selective Kv1.5 channel blocker 
Stromatoxin-1(STTX) selective Kv2.1 channel blocker 
Acetylcholine endogenous neurotransmitter active at acetylcholine receptors 
Methoxamine α1-adrenergic receptor agonist  
 
In real-time PCR experiments: 
Name Catalogue No. Manufacturer 
RNeasy Mini Kit (50) 74104 QIAGEN 
Qiazol Lysis Reagent 5,346,994 QIAGEN Sciences 
RNase-Free DNase Set (50) 79254 QIAGEN 
Ethanol (90%)  T9132  Roth 
   
5×Reaction Buffer #EP0452 Thermo scientific 
dNTP Mix, 10 nM each #R0192 Thermo scientific 
RevertAid H Minus ReverseTranscriptase  #EP0451 Thermo scientific 
Random Primers  48190-011 Invitrogen 
   
Water, nuclease-free  #R0581 Thermo scientific 
SensiFAST™ SYBR No-ROX Kit, 2× BIO-98020 Bioline 
Primers * - Eurofins 
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*- Specific primers in qPCR 
Gene Forward Primer Primer Sequence Size (bp) Dilution 
Reverse Primer    5´→ 3´ 
KCNQ1 ratfor1int GGCTCTGGGTTTGCACTG (18) 105 1:100 
ratrev3 CATAGCACCTCCATGCAGTC (20) 1:100 
KCNQ2 for_1 ACACAGACTCAGACCTCTGCAC (22) 115 1:100 
rev_1 AGCCCAACCCAGAATCACTTCC (22) 1:100 
KCNQ3 rat for new GCTAGGGACCGGAGCCGACA (20)  192 1:100 
rat rev new CCCCTCGGTCTCTCCAGGGC (20) 1:100 
KCNQ4 ratfor1int CCCCGCTGCTCTACTGAG (18)  86 1:100 
ratrev2 ATGACATCATCCACCGTGAG (20) 1:100 
KCNQ5 ratfor2out GATGCCAGTGTGACGTGTCCGTGG (24)  393 1:100 
ratrev2 CCTTTCCGAGGACCTGCTGGTAG (23) 1:100 
rBKalpha for Yan AAACAAGTAATTCCATCAAGCTGGTG(26) 137 1:100 
rev Yan CGTAAGTGCCTGGTTGTTTTGG(22) 1:100 
rBKbeta1 for3 ACCAATCTCTTCTGCACAGCAGC(23) 378 1:100 
rev3 AGAGCTGTGACTGGCAGTTCCTT(23) 1:100 
eNOS rat for1   GGATTCTGGCAAGACCGATTAC (22)  159 1:100 
rat rev1 GGTGAGGACTTGTCCAAACACT (22) 1:100 
Hmbs for_1 GCGGAAGAAAACGGCTCAATG (21)  95 1:100 
rev_1 AGCATCGCTACCACAGTGTC (20) 1:100 
2.1.4 Essential buffers  
Experimental solution (pH 7.4, 37°C)   
(To simulate the in vivo environment of vessels in wire myograph experiments) 
Reagent MW (g/mol) Concentration (mmol/L) 
NaCl  58,44 120 
NaHCO3 84,01 26  
KCl  74,55 4.5  
NaH2PO4*H2O  137,99 1.2 
MgSO4*7H2O  246,48 1  
CaCl2*2H2O 147,02 1.6 
EDTA   292,25 0.025  
Glucose 180,16 5.5  
Hepes   238,31 5  
 
Experimental solution without NaHCO3 (pH 7.4, 37°C) 
(To simulate the in vivo environment of vessels in pressure myograph experiments) 
Reagent MW (g/mol) Concentration (mmol/L) 
NaCl  58,44 146 
NaHCO3 84,01 - 
KCl  74,55 4.5  
NaH2PO4*H2O  137,99 1.2 
MgSO4*7H2O  246,48 1  
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CaCl2*2H2O 147,02 1.6 
EDTA 292,25 0.025 
Glucose 180,16 5.5  
Hepes  238,31 5  
 
Preparation solution (pH 7.4, 37°C)   
(To keep vessel viable during isolation, mounting on wire myograph and normalization processes) 
Reagent MW (g/mol) Concentration (mmol/L) 
NaCl  58,44 145 
KCl  74,55 4.5 
NaH2PO4*H2O   137,99 1.2 
MgSO4*7H2O  246,48 1 
CaCl2*2H2O 147,02 0.1 
EDTA  292,25 0.025 
Hepes  238,31 5 
 
Calcium-free solution (pH 7.4, 37°C)    
(To determine the passive diameter of the vessels at the end of pressure myograph experiments)  
Reagent MW (g/mol) Concentration (mmol/L) 
NaCl  58,44 120 
NaHCO3 84,01 26 
KCl  74,55 4.5  
NaH2PO4*H2O   137,99 1.2 
MgSO4*7H2O  246,48 1  
EGTA 380,35 1 
Hepes 238,31 5 
Glucose 180,16 5.5 
 
2.1.5 Instruments  
In myograph experiments: 
Name Type Manufacturer 
Multi Wire Myograph system 620M Danish Myo Technology A/S (DMT) 
Pressure Myograph system  DMT 
Nylon suture 100115 DMT  
Stainless steel wire 40 μm DMT 
Forceps  5-Inox-H Fine Science Tools 
Vannas Capsulotomy Scissors  G19760 Geuder 
Stereo Microscope Stimmi 2000-C Zeiss 
Laboratory pH meter Lab 850 SCHOTT instruments 
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In real-time PCR experiment: 
Name Type Manufacturer 
Tissue Lyser II QIAGEN 
NanoQuant Plate Infinite 200 PRO TECAN 
Mastercyler  Gradient 5333 Eppendorf 
Light Cycler  480   Roche 
Microcentrifuge CT15RE VWR 
 
2.1.6 Software  
Name Manufacturer/Designer 
LabChart 7 Software model MKIIII AD Instruments Pty Ltd, Germany 
HaSoTec Bloodvessel Analyzer, BVA 300 HaSoTec, Germany 
Light Cycler 480 software  Roche 
LinRegPCR software Academic Medical Center, Netherlands 
GraphPad Prism 6 GraphPad Software, USA 
Inkscape 0.48  
 
2.2 Methods 
2.2.1 Isolation of arteries  
 Once the rat was decapitated, the hind limbs were severed from the rat body. 
 The leg was placed in a petri dish with cold preparation solution. 
 Under the microscope, the arteries (A. Gracilis and A. Saphena) were carefully 
isolated from the leg muscle and all connective tissue. 
2.2.2 Pressure myograph experiments 
This method is a newer approach to investigate physiological functions of vessel 
segments under isobaric conditions, in which a cannulated vessel segment is 
mounted between a perfusion pipette and a holding pipette. The perfusion pipette is 
connected to a pressure reservoir. The holding pipette is closed to prevent flow 
through the vessel lumen. Through the perfusion pipette, the A. Gracilis receives 
different levels of pressure that can stimulate the artery to perform myogenic 
responses. The myogenic response, also known as the “Bayliss effect”, is an intrinsic 
reaction of small arteries to changes of intravascular pressure, in which the artery 
can constrict further or dilate from an original partially contracted state (myogenic 
tone) (Bayliss 1902, Osol et al. 2002). These responses can be detected as diameter 
changes of an artery. In this study, the changes of myogenic responses were 
observed when the artery was challenged with different activators and inhibitors of 
potassium channels (Fig. 2.2). 
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Figure 2.2 Scheme of the arrangement of a pressure myograph experiment 
After the artery is mounted, the myograph chamber is placed onto the work stage containing a microscope 
(objective 10×/0.25) fitted with a video camera, and connected to the heater and the solution perfusion pump. 
Meanwhile, the perfusion pipette of the chamber is connected to a pressure reservoir, allowing the pressure in the 
artery to be precisely controlled and altered. The image of the artery is shown on a monitor and the diameter of 
the artery can be continuously measured throughout the experiment. 
2.2.2.1. Mounting of arteries  
 An isolated A. Gracilis segment (approx. 2 mm long) was placed into the 
pressure myograph chamber with fresh experimental solution without NaHCO3 
(chamber volume = 1.5 ml).  
 Two suture loops were positioned appropriately on each glass pipette (ready for 
following mounting procedure). 
 The isolated A. Gracilis was mounted to the perfusion pipette firstly, and secured 
onto the pipette by tightening the suture loop around it. 
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 The endothelium was disrupted by gently pushing a few air bubbles through the 
vessel lumen from the perfusion pipette with use of a syringe. 
 The free end of A. Gracilis was gently fixed on the holding pipette.  
 The chamber was placed onto the pressure myograph work stage, and 
connected to the solution pump for chamber perfusion and the pressure reservoir 
(at 10mmHg).  
2.2.2.2. Initial incubation of arteries 
 The chamber was heated to 37°C throughout the experiment. 
 The solution pump was switched on to keep the experimental solution without 
NaHCO3 fresh in the chamber (perfusion rate 1.5ml/min). 
 The pressure reservoir was slowly positioned to the level of 80 mmHg. 
 After the first 30 minutes, the bath solution mixer was fixed into the chamber 
beside the artery. 
 After the second 30 minutes, the solution pump was switched off for 10min. 
2.2.2.3. Viability test  
 Application of methoxamine 10-5 mol/L, 3 min (to test the contractile activity of the 
artery).  
 Application of acetylcholine 10-5 mol/L, 2min (to assess endothelium function). 
 Wash out (pump on and off, 10 min each) 
2.2.2.4. Myogenic response experiment 
 MRs, 5min at each pressure level   
- MRs represents ‘Myogenic Responses’ performed at 4 different pressure 
levels by changing pressure from 80 to 10, 40, 80, 120 mmHg and then back 
to 80 mmHg 
Wash out (pump on and off, 10 min each) 
 
 MRs, 5min at each pressure level, to test stability of MRs 
Wash out (pump on and off, 10 min each) 
 
 Each chamber underwent treatments in the following sequence : 
Chamber 1 Chamber 2 Chamber 3 Chamber 4 
A*(Table 2.1) A As  As  
B  Bs Bs B  
 MRs, 5min at each pressure level 
Wash out (pump on and off, 10 min each) 
 
 MRs, 5min at each pressure level 
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 Calcium-free solution was used to replace the experimental  solution in the 
chamber, 15 min  
MRs, 4min at each pressure level 
 
*Table 2.1 Treatments A, As, B, Bs in different series in pressure myograph experiment 
series A (mol/L) As (μl) Time(min) B (mol/L) Bs (μl) Time(min) 
1 NS19504 
3×10
-6
 
DMSO 
1.5 
10 IBTX 
10
-7
 
H2O   
5 
10 
2 Retigabine 
3×10
-6 
DMSO 
1.5 
10 XE991 
3×10
-6
 
H2O   
1.5 
10 
3 Retigabine 
3×10
-6 
DMSO 
1.5 
10 NS19504  
3×10
-6 
DMSO 
1.5 
15 
4 NS19504 
3×10
-6 
 
DMSO 
1.5 
15 XE991 
3×10
-6
 
H2O   
1.5 
10 
5 XE 991 
3×10
-6
 
H2O 
1.5 
10 IBTX 
10
-7
 
H2O  
5 
10 
6 Retigabine 
3×10
-6
 
DMSO 
1.5 
10 IBTX    
10
-7
 
H2O   
5 
10 
7 HMR1556 
10
-5
 
DMSO 
5 
10 IBTX    
10
-7
 
H2O   
5 
10 
8 DPO-1 
3*10
-7
 
DMSO 
1.5 
10 IBTX    
10
-7
 
H2O   
5 
10 
9 STXX 
10
-7
 
H2O 
5 
10 IBTX    
10
-7
 
H2O   
5 
10 
 
2.2.2.5. Analysis of pressure myograph data 
The normalized diameter is used to compare the myogenic responses between 
different arteries treated with different substance, which is the diameter of arteries in 
MRs (Dx) divided by their diameter at 80 mmHg in calcium-free solution (D80max). 
Normalized Diameter =Dx /D80max 
2.2.3 Wire myograph experiments 
Wire myography is another classical method developed in the 1970s to investigate 
the function of blood vessels under isometric conditions (Bevan and Osher, 1972). 
This method employs two stainless steel wires that are passed through the lumen of 
ring vessel segments and hold it at a certain constant internal circumference (IC). As 
one of the wires is connected to a force transducer, the tension of vessels under 
different activation conditions can be measured (Fig. 2.3). In this study, the tension of 
A. Saphena generated by methoxamine was recorded during application of different 
activators or inhibitors of potassium channels. 
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Figure 2.3  Wire myograph system 
(www.dmt.dk, Stand 06.04.2017), modified 
 A) Multi wire myograph system 620M (DMT) with four myograph chambers allowing four vessels to be 
simultaneously studied. B) Each myograph chamber contains two jaws to fix two wires supporting the vessel 
segment. The left-hand jaw and the right-hand jaw are connected to a force transducer and a micrometer, 
respectively.  
 
2.2.3.1. Mounting of arteries 
 The isolated A. Saphena segment (approx. 2 mm long) was transferred into the 
wire myograph chamber with fresh cold preparation solution (chamber volume = 
5ml). 
 One end of a stainless steel wire (approx. 2.5 cm long) was fixed under the upper 
screw of the left-hand jaw of the chamber (Fig. 2.4 1-2). 
 The artery was gently pulled on and then along the wire with fine forceps to feed 
the wire onto it (Fig. 2.4 3-4). 
 When the artery is situated in the gap between the jaws, the free end of the wire 
was secured under the lower screw of the left-hand jaw (Fig. 2.4 5-6).  
 The second wire was gently feeded through the lumen of the vessel after the 
jaws were moved apart by the micrometer (Fig. 2.4 7-8). 
 The jaws were moved together and the second wire was secured under the 
screws of the right-hand jaw (Fig. 2.4 9-12).  
 The jaws were moved apart again to slightly stretch the mounted vessel segment, 
allowing a piece of a rat whisker to pass through the artery lumen  
 The endothelium of the artery was completely rubbed away by turning the 
whisker around in the lumen. 
 The jaws were moved together to position the two wires very close to each other. 
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 The other three chambers were mounted with vessels subsequently. 
 The chambers were placed on the interface of the Wire Myograph set-up, with 
heating (37°C) and gassing (95% O2 and 5% CO2) for 20 min 
 
 
 
Figure 2.4 wire myograph mounting steps 
(www.dmt.dk, Stand 06.04.2017), modified 
(1)-(2) Fixation of a stainless steel wire (approx. 2.5 cm long) on the left-hand jaw of the wire myograph chamber; 
(3)-(6) Mounting of a vessel onto the fixed wire; (7)-(12) Fixation of the second wire passed through the lumen of 
the vessel on the right-hand jaw. 
2.2.3.2. The normalization procedure  
This procedure is most critical, because it not only sets the artery to an optimal 
physiological internal circumference (IC, Fig. 2.5 B) to create a suitable resting 
tension that ensures that the artery displays optimal responses to vasoactive agents, 
but also provides standard experimental baseline conditions to perform comparative 
measurements on different vessels.  
The normalization procedure is performed based on the muscular length tension 
relationship to acquire the value of passive vessel internal circumference at a 
pressure of 100 mmHg (13.3 kPa) (IC100) and then the vessel is set to the optimal 
internal circumference (IC1). 
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As known, the length tension relationship describes the phenomenon that with  
different length, muscle exhibits different levels of maximum isometric force (Gordon 
et al., 1966). This relationship comprises passive and active parts: 
1) the passive length tension relationship  
In the absence of agonists i.e. without the interaction between the myosin and 
actin filaments, muscle tension is increased with increasing length by stretch.  
In the normalization procedure, based on the data of passive tension of the artery 
and the corresponding applied ICs obtained using the micrometer, this passive 
length tension relationship is plotted, and the IC100 can be determined according 
to La Place’s Law (Fig. 2.5 C blue line).  
La Place’s Law 
The effective pressure (Pi) = Wall tension / (internal circumference/(2 × π)) 
 
 
 
 
Figure 2.5 Conceptual illustration of wire myograph normalization principles 
(www.dmt.dk, Stand 06.04.2017), modified 
A) The ideal optimal relative position of myosin and actin filaments can provide the two filaments with maximal 
extent of contact but still leaves proper space for a maximal constriction. The stretched distance applied in this 
position corresponds to IC1. 
B) In wire myography, the value of the internal circumference of vessels (IC) is related to the diameter of the 
wires that hold the artery and the distance of the gap between the wires. The vessel is stretched as the gap is 
getting larger by manipulating the micrometer. 
C) The typical separated components of the length/tension graph: the passive stretch line (blue) represents, in 
the absence of agonists, vessel tension increases with increasing IC obtained by manipulating the myograph 
micrometer. The IC100 value is found by plotting this passive line in the normalization procedure. The active 
line (green) reflects the changes in vessel tension generated by an agonist at different length conditions (i.e. 
force contributions only from muscle contraction without passive stretch). The value of IC that corresponds to 
the maximum agonist response is represented by IC1 (dashed green line).  
 
 
2) The active length tension relationship: 
The length of the muscle reflects the extent of contact between the myosin and 
actin filaments. The optimal active responses in force can only be developed 
when the artery stays at an optimal length where the two filaments have maximal 
contact but still have proper space for contraction (Fig. 2.5 A, C green line). 
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In the normalization procedure, IC1 represents the optimal length, which can be 
calculated from IC100.  
IC1 = Normalization Factor × IC100  
(Normalization Factor depends on the type of vessel and the species used) 
The procedure of normalization:  
 The Normalization Module in the LabChart software was started.  
 The artery was stretched stepwise by manipulating the micrometer (at first two 
steps of about 300 μm each and then the step size was decreased according to 
individual vessels to acquire passive tension points.  
 When the last passive tension point is above the isobar line of 100 mmHg (13.3 
kPa), the normalization is terminated. At this step, the passive IC100 was 
determined and the optimal IC1 was calculated automatically by this module.  
- There should be at least 4 passive tension points (3 points below the isobar 
line and 1 point just above) to allow the Normalization Module to calculate an 
exponential curve fitting to determine the passive IC100, and calculate the 
optimal IC1.  
- In this study, IC1 = 90% × IC100 (Normalization Factor=0.9) (Mulvany and 
Halpern, 1977). 
 The artery is set to IC1.  
 
 
Figure 2.6 Output window of wire myograph normalization  
The big window is the main LabChart window displaying the force trace obtained by the stepwise increase in 
stretch; The small window automatically plots the passive stretch line dependent on the steps of stretch set by 
the micrometer and the corresponding artery passive tension, at the end the value of IC1 is generated. 
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2.2.3.3. Viability test  
 The preparation solution in the chambers was changed to experimental solution. 
 Application of methoxamine 10-5 mol/L, 5 min (to test the contractile activity of 
arteries). 
Application of acetylcholine 10-5 mol/L, 2 min (to assess endothelium function). 
Wash 3×-1×-1×, 5min each   
- i.e., each artery was washed 3 times with 5 minutes interval each. The first 
time included 3 consecutive washes, the other two only one wash (complete 
solution change of the chamber).  
2.2.3.4. The main experiment 
 Application of methoxamine 10-5 mol/L, 5 min (to acquire the maximum tension of 
the artery, Tmax) 
Wash 3×-1×-1×, 5min each 
 Application of H2O(treatments As+Bs*, Table 2.2),  20min  
Methoxamine CRC, 3min at each concentration 
- Methoxamine CRC: Methoxamine Concentration Responses Relationship 
using 7 different concentrations (10-8, 3×10-8, 10-7, 3×10-7, 10-6, 3×10-6, 10-5 
mol/L) 
Wash 3×-1×-1×, 5min each 
 Each chamber underwent treatments in the following sequence: 
Channel 1 Channel 2 Channel 3 Channel 4 
As (Table 2.2) 
B  B Bs B  
 Methoxamine CRC   3min at each concentration 
Wash  3×-1×-1× 5min each 
A As A As 
B  B Bs Bs  
 Methoxamine CRC   3min at each concentration 
Wash  3×-1×-1× 5min each 
 
*Table 2.2 treatments A, As, B and Bs in different series in wire myograph experiment 
series A (mol/L) As  (μl) B (mol/L) Bs  (μl) Time  
1  NS19504   3×10-6 DMSO  1.5 IBTX        10-7 H2O     5 10 min 
2 Retigabine 3×10-5 DMSO  1.5 XE991      3×10-6 H2O     1.5 10 min 
3 NS19504   3×10-6 DMSO  1.5 XE991      3×10-6 DMSO 1.5 10 min 
4 XE991       3×10-6 H2O      1.5 IBTX         10
-7 H2O     1.5 10 min 
5 Retigabine 3×10-5 DMSO  1.5 NS19504  3×10-6 H2O      5 10 min 
6 Retigabine 3×10-6 
10
-5
 
DMSO  1.5  IBTX         10-7 H2O      5 10 min 
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2.2.3.5. Analysis of Wire Myograph data 
Relative tension is used to indicate the intensity of artery contraction, which is the 
artery tension generated by methoxamine divided by the maximum tension at 
methoxamine 10-5M (Tmax) determined at the beginning of the experiment. 
Relative Tension = Tx / Tmax 
2.2.4 Real-time PCR 
In order to get insight into the relationship between the physiological function of 
arteries and the potassium channel gene expression profile, the Real-Time 
quantitative polymerase chain reaction (qPCR) technique was applied in this study. 
We isolated total RNA from arteries firstly, then reverse transcripted RNA into cDNA, 
and at the end detected the amount of cDNA templates by use of qPCR.  
2.2.4.1. Collection of artery samples  
Artery samples were collected in two groups: arteries with endothelium (E+) and 
arteries without endothelium (E-). 
 Once the hind limb of the rat was severed, a whole piece of artery (A. Saphena 
and A. Gracilis) was isolated immediately in icy preparation solution. 
 In the E+ group, the blood in the artery lumen was removed by forceps,  
In the E- group, the endothelium was completely rubbed away by strongly turning 
a piece of rat whisker around inside the artery lumen (as mentioned in the wire 
myograph method).  
 Artery samples were put into 2.0μl tubes, frozen in liquid nitrogen and stored at    
-80°C  
2.2.4.2. Purification of total RNA  
 The tube containing an artery sample was put on ice and 700 µl QIAzol Lysis 
Reagent and one steel bead were added.  
 The TissueLyser II was used to disrupt and homogenize the artery immediately 
(30Hz, 6min).  
 The homogenate was incubated at room temperature (20-25°C) for 5 min. 
 140µl chloroform was added and the tube was shaken vigorously for 15 s. 
 The tube was incubated at room temperature for 2-3 min.  
 The tube was centrifuged at 12,000xg and 4°C for 15min. 
 After centrifugation, the sample was separated into 3 phases. The upper 
colorless aqueous phase containing RNA (volume approximately 350 µl) was 
transferred into a new collection tube with 1.5 volumes (525 µl) of 100% ethanol 
and mixed thoroughly by pipetting up and down several times.  
 700 µl of the sample was pipetted into an RNeasy Mini spin column in a 2 ml 
collection tube, and centrifuged at≥8000 x g (≥10,000 rpm) for 15 s at room 
temperature (20-25°C).  
The flow-through was discarded. 
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 The last step was repeated with the remainder of the sample. 
 
- DNase digestion  
 350 µl of washing buffer RW1 was pipetted to the RNeasy Mini Spin Column and 
centrifuged for 15 s at ≥8000 x g (≥10,000 rpm).  
The flow-through was discarded. 
 10 µl DNase I stock solution was added to 70 µl Buffer RDD and gently mixed.  
 The DNase I incubation mix (80µl) was pipetted directly on to the RNeasy Mini 
Spin Column membrane and incubated at 20–30°C for 15 min.  
 350 µl buffer RW1 was pipetted to the RNeasy Mini Spin Column and centrifuged 
for 15 s at ≥8000 x g (≥10,000 rpm).  
The flow-through was discarded. 
 500 µl buffer RPE was pipetted to the RNeasy Mini spin column and centrifuged 
for 15 s at ≥8000 x g (≥10,000 rpm). 
The flow-through was discarded. 
 The last step was repeated, but centrifuged for 2min at ≥8000 x g (≥10,000rpm) 
to dry the RNeasy Mini spin column membrane.  
 The RNeasy Mini spin column was placed into a new 2 ml collection tube, and 
centrifuged for 1 min at full speed to eliminate any possible carryover of buffer 
RPE.  
 The RNeasy Mini spin column was transferred to a new 1.5 ml collection tube, 
and pipetted with 30µl RNase-free water directly onto the RNeasy Mini spin 
column membrane and centrifuged for 1 min at ≥8000 x g (≥10,000 rpm) to elute 
the RNA.  
 The last step was repeated with the first eluate and the same collection tube to 
obtain a higher total RNA concentration.  
2.2.4.3. Measurement of RNA concentration 
 The RNA sample was measured by TECAN with the Nano Quant plate.  
- The concentration of the RNA should be above 10ng/µL, the ratio (260 / 280 
nm) between 1.8 and 2.1. 
 The RNA sample was stored at -80°C. 
2.2.4.4. Complementary DNA (cDNA) synthesis 
 The reverse transcript synthetic solution was prepared following Table 2.3, in 
which each 20μl synthetic solution contains 100 ng RNA: 
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                     Table 2.3 Reverse transcript synthetic solution 
Reagent  Volume(μl) 
RNA (100 ng) + RNase free H2O  12 
5×Reaction Buffer 4 
Random Primers  0.2 µg/µL  1 
dNTP Mix, 10 nM each 2 
RevertAid H Minus Reverse Transcriptase 200 U/µl 1 
 
Total volume 
 
20 
 
 The reversed transcription was performed by Mastercyler gradient.  
- the synthesis progress was set as: 
 
                     Table 2.4 Reversed transcription synthesis progress 
Temperature  Time  
20°C 10 min 
50°C 60 min 
70°C 10 min 
4°C ∞ 
 
 The cDNA was stored at -20°C.  
2.2.4.5. Real time PCR (qPCR) 
The traditional PCR only measures the amount of PCR product at the end point of 
the amplification, while qPCR can detect the intensity of fluorescence of PCR 
products generated at the end of each amplification cycle, and then extrapolate back 
to the initial amount of DNA or cDNA template with higher sensitivity and specificity. 
A typical qPCR includes 4 basic phases (Fig. 2.7):  
- Initiation phase: It is at the first PCR cycles in which the amount of the 
products is too low to distinguish their fluorescence from the background 
signal (baseline).  
- Exponential phase: In this phase, the fluorescence signal of products has 
reached and is above the detection threshold with an exponential increase. 
The first fractional PCR cycle above the detection threshold is called 
threshold cycle (Ct Value). As all of the reagents are fresh and available in 
this phase, the reaction becomes very specific and precise, and the efficiency 
indicating how completely the amplicon amplified in each cycle approaches 2. 
The amount of initial DNA templates is extrapolated from the Ct value and the 
efficiency in this phase.  
- Linear phase: with the reaction reagents consumed, the reaction becomes 
slower, and reaches significant product inhibition.  
- Plateau phase: with the reagents exhausted, the reaction has stopped, in 
which there is no more products made and no increase in fluorescence 
detected.  
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Figure 2.7 Nomenclature in a typical qPCR amplification plot 
(Arya et al. 2005), modified 
The plot is based on the PCR products fluorescence data collected in each PCR cycle and demonstrates initiation 
phase (baseline), exponential phase, linear phase and plateau phase. 
ΔRn= Fluorescence of the product at each cycle – fluorescence of the baseline 
Ct= Threshold cycle 
There are some DNA-binding dyes or fluorescent probes that can be employed as 
fluorescent labels in qPCR. In this study, SYBR Green as a non-sequence-specific 
DNA-binding dye was used. The unbound SYBR Green exhibits little fluorescence, 
while the one intercalating into the Minor Groove of double stranded DNA (dsDNA) 
would emit fluorescence. Therefore, the more dsDNA amplicons are produced, the 
stronger is the fluorescence emitted by SYBR Green. (Fig. 2.8) However, according 
to this mechanism, nonspecific PCR products and primer-dimers could decrease its 
specificity. Since the characteristic melting peak at the melting temperature (Tm) of 
the amplicon is specific for the corresponding PCR product, the melting curve at the 
end of qPCR is necessary to distinguish amplification artifacts and to increase the 
specificity of the reaction (Arya et al., 2005). 
 
In this study, each gene was tested in triplicates for one sample in a qPCR 96-well 
plate including a reference gene (Hmbs) as control. 
Figure 2.8 Detection mechanism of double-
stranded DNA-binding dye SYBR Green 
(http://www.bioneercn.com/products_detail014/&prod
uctId=ea3d0846-b14c-4a34-8bca-d5e2b3c89cfb.html, 
Stand 06.04.2017), modified 
The unbound SYBR Green exhibits little fluorescence 
during the denaturation step. From annealing, 
especially in the extension step as soon as SYBR 
Green binds to double-stranded DNA products, it 
emits fluorescence. 
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 SYBR Mix was prepared according to Table 2.5. 
Table 2.5 Composition of SYBR Mix 
Regagent  Volume/well (μl) 
cDNA Template  2 
SensiFAST™ SYBR No-ROX Kit, 2×  10 
Nuclease free H2O  3 
Forward primer  2.5 
Reverse primer  2.5 
Total volume  20 
 18µl of the SYBR mix was added into each well. 
 2µl of corresponding cDNA was added to each well. 
 The plate was sealed with self-adhesive sealing foil, centrifuged shortly and 
loaded into the Light Cycler 480 machine. 
 The program of Light Cycler was started, and the amplification progress was set 
according to Table 2.6. 
Table 2.6 reaction parameters of real-time PCR progress 
step Hold Target(°C) Acquisition Mode Ramp-Rate (°C/s)  
 
Acquisitions (°C) 
 
Cycles 
Denaturation 2 min   95 None 4.4 -  1 
Amplification 
 Annealing 
 Elongation 
 
5 s 
30 s 
 
95 
60 
 
None 
Single 
 
4.4 
2.2 
 
- 
- 
47 
Recording  
melting curve 
1 min 
1 min 
1 s 
- 
95 
40 
60 
95 
None 
None 
None 
Continuous 
4.4 
2.2 
1 
0.6 
- 
- 
- 
10 
1 
Cooling 10 s 40 None 2.2 - 1 
2.2.4.6. Analysis of real-time-PCR data 
 Melting curves were checked by use of the Light Cycler 480 software to ensure 
the specificity of qPCR products. 
 The threshold cycle number (Ct) and amplification efficiency (E) were calculated 
using the LinRegPCR program  
 The expression of the target gene was normalized against Hmbs (reference 
gene): 
Relative Expression = ECt (Hmbs)/ ECt (target) 
2.2.5 Statistics  
All data are presented as mean ± the standard error of the mean (SEM); n is the 
number of animals. Multiple data from different groups were analyzed using repeated 
measures ANOVA followed by post-hoc test (Holm-Sidak), single data from two 
groups were compared by an unpaired t test.  
In this study, p<0.05 was considered to be statistically significant. 
RESULTS 
32 
3 RESULTS 
3.1 Expression of Kv7 and BK channel genes in rat skeletal muscle arteries 
To determine which subunits of KCNQ and BK channels are expressed in the A. 
Saphena and A. Gracilis, the arteries were studied in two groups, with endothelium 
(E+) and without endothelium (E-), by use of the qPCR technique.  
lg
[R
e
la
ti
v
e
 E
x
p
r
e
s
s
io
n
]
K C N Q 1 K C N Q 2 K C N Q 3 K C N Q 4 K C N Q 5 B K  α B K  β 1 e N o s
0 .0 1
0 .1
1
1 0
1 0 0
A .S a p h e n a  E +
A .S a p h e n a  E -
*****
lg
[R
e
la
ti
v
e
 E
x
p
r
e
s
s
io
n
]
K C N Q 1 K C N Q 2 K C N Q 3 K C N Q 4 K C N Q 5 B K  α B K  β 1 e N o s
0 .0 1
0 .1
1
1 0
1 0 0
A .G ra c ilis  E +
A .G ra c ilis  E -
***
***
 
Figure 3.1.1 Expression of KCNQ and BK channel genes 
A) Relative expression (normalized by Hmbs) profile of KCNQ and BK channel genes in Saphenous artery 
(A.Saphena) with endothelium (E+) and without endothelium (E-). B) Relative expression profile of KCNQ 
and BK channel genes in Gracilis artery (A.Gracilis) with endothelium (E+) and without endothelium (E-).  
n=8;**- p<0.01; *** - p<0.001. 
 
In general, the expression profiles of the potassium channel genes in A. Saphena 
were similar to those in A. Gracilis: the highest expression was observed for BKα, 
BKβ1 and KCNQ4, followed by KCNQ1, KCNQ5 and KCNQ3 at a lower expression 
levels. The lowest expressed gene was KCNQ2 (Fig. 3.1.1).  
Comparing the E- group with the E+ group, for A.Saphena (Fig. 3.1.1A), eNOS as a 
marker for the endothelium, in the E- group represented only 5.7% of that in the E+ 
group, but the expression of the potassium channel genes was similar, except that 
KCNQ4 in the E+ group was lower than that in the E- group. For A. Gracilis, (Fig. 
3.1.1B), besides the significant difference that there was only 27% eNOS in the E- 
group compared with the E+ group of A. Gracilis, as with A.Saphena, the data also 
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indicate that the expression of almost all KCNQ and BK channel genes were similar, 
except lower KCNQ4 in the E+ group.  
3.2 Function of Kv7 and BK channels in rat skeletal muscle arteries  
In this study, the function of Kv7 and BK channels was studied by application of their 
respective blockers and activators. Specifically, XE991 was used as a selective 
blocker of Kv7 channels (Greenwood and Ohya, 2009), retigabine as a selective 
activator of Kv7 channels (Wickenden et al., 2000); iberiotoxin (IBTX) was used as a 
selective blocker of BK channels (Galvez et al., 1990), and NS19504 as a novel 
activator of BK channels (Nausch et al., 2014). 
3.2.1 Respective function of Kv7 and BK channels 
3.2.1.1 Effect of Kv7 channel blocker and activator on arterial contractility 
Firstly, the actions of the Kv7 channel blocker XE991 and activator retigabine were 
studied on methoxamine-induced contractions in wire myograph (Fig 3.2.1) and on 
pressure-induced myogenic responses in pressure myograph  (Fig 3.2.3) experiments. 
Regarding methoxamine-induced contractions, it was observed that arterial tension was 
dramatically attenuated by retigabine at 3*10-5M, but not changed by XE991 alone at 
3*10-6M. The tension in the combined presence of retigabine and XE991 was stronger 
than that in the presence of retigabine alone, but similar to that in the presence of XE991 
alone (Fig 3.2.2 A). Thus, in the presence of XE991, retigabine was not able to affect 
methoxamine-induced tension. Correspondingly, the anti-contractile effect of retigabine 
was decreased in the presence of XE991 (Fig 3.2.2 B) while the functional availability of 
Kv7 channels, expressed as the contractile effect of XE991, was notably increased in the 
presence of retigabine (Fig 3.2.2 C).  
 
Figure 3.2.1 Original recordings of methoxamine-induced contractions in the presence of XE991 and 
retigabine in a wire myograph experiment 
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Figure 3.2.2 Effect of retigabine and XE991 on methoxamine-induced contractions 
A) Normalized tension of A.Saphena with different methoxamine concentrations in the absence of Kv7 channel 
active agents (Control), in the presence of XE991 (XE991 3*10
-6
M), in the presence of retigabine (Retigabine 
3*10
-5
M) and in the combined presence of retigabine and XE991 (Retigabine + XE991). B) Anti-contractile effect 
of retigabine in the absence (Control) and presence of XE991 (XE991 3*10
-6
M). C) Contractile effect of XE991 
(Kv7 channel functional availability) in the absence (Control) and presence of retigabine (Retigabine 3*10
-5
M). 
n=9; * - p<0.05, **- p<0.01; *** - p<0.001.  
Similar results were obtained for myogenic responses: retigabine at 3*10-6M 
weakened the myogenic response, while XE991 at 3*10-6M strengthened it. The 
myogenic response in the presence of XE991 and retigabine together was as strong 
as that with XE991 alone (Fig 3.2.4 A). Of note, XE991 attenuated the anti-contractile 
effect of retigabine (Fig 3.2.4 B), whereas retigabine enhanced the functional 
availability of Kv7 channels (Fig 3.2.4 C).  
The mutual complete inhibition of their respective effects indicates that XE991 and 
retigabine in the concentrations applied can be employed as a selective Kv7 channel 
activator and blocker, respectively. 
 
Figure 3.2.3 Original recordings of myogenic responses in the presence of XE991 and retigabine in a 
pressure myograph experiment 
RESULTS 
35 
 
0 2 0 4 0 6 0 8 0 1 0 0 1 2 0
0 .5
0 .7
0 .9
1 .1
1 .3
P re s s u re  (m m H g )
N
o
r
m
a
li
z
e
d
 d
ia
m
e
te
r
 (
%
)
X E 9 9 1 3 *1 0 -6 M
R e tig a b in e  +  X E 9 9 1
C o n tro l
R e tig a b in e 3 *1 0 -6 M
*
*
**
p = 0 .9 0
C o n tro l X E 9 9 1  3 *1 0
-6
M
0
1 0
2 0
3 0
R
e
ti
g
a
b
in
e
a
n
ti
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
* * *
C o n tro l R e t ig a b in e  3 *1 0
-6
M
0
1 0
2 0
3 0
X
E
9
9
1
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
* * *
A B
C
 Figure 3.2.4 Effect of retigabine and XE991 on the myogenic response 
A) Normalized diameter of A.Gracilis with different intra-luminal pressures in the absence of Kv7 channel active 
agents (Control), in the presence of XE991 (XE991 3*10
-6
M), in the presence of retigabine (Retigabine 3*10
-6
M) 
and in the combined presence of retigabine and XE991 (Retigabine and XE991). B) Anti-contractile effect of 
retigabine in the absence (Control) and presence of XE991 (XE991 3*10
-6
M). C) Contractile effect of XE991 (Kv7 
channel functional availability) in the absence (Control) and presence of retigabine (Retigabine 10
-7
M). n=10; * - 
p<0.05, **- p<0.01; *** - p<0.001. 
 
3.2.1.2 Effect of BK channel blocker and activator on arterial contractility 
Meanwhile, the action of the BK channel blocker IBTX and activator NS19504 was 
also studied on methoxamine-induced contractions in wire myograph (Fig 3.2.5) and 
on pressure-induced myogenic responses in pressure myograph experiments (Fig 
3.2.7). 
Because there is no agent commonly recognized and confirmed as a selective 
activator of BK channels till now, NS19504 as a novel candidate was tested in more 
detail, i.e. in three concentrations (3*10-6M, 6*10-6M, 10-5M), in wire myograph 
experiments to detect whether it is a real potent and selective activator of BK 
channels in arterial smooth muscle. 
It was observed that the methoxamine-induced arterial tension was increased by 
IBTX at 10-7M, while attenuated by NS19504 (3*10-6M, 6*10-6M, 10-5M) in a 
concentration-dependent manner. Notably, the tension in the presence of IBTX 
combined with NS19504 (3*10-6M, 6*10-6M) was similar to that in the presence of 
IBTX alone (Fig 3.2.6 A1, A2). However, with the concentration of NS19504 
increased to 10-5M, the tension in the presence of the combination of IBTX and 
NS19504 was weaker than that in the presence of IBTX alone. Thus, in the presence 
of IBTX, the lower concentrations of NS19504 were not able to affect methoxamine-
induced contractions. Furthermore, the anti-contractile effect of NS19504 was 
decreased in the presence of IBTX (Fig 3.2.6 B1, B2, B3), whereas the functional 
availability of BK channels, expressed as the contractile effect of IBTX, was 
increased in the presence of NS19504 (Fig 3.2.6 C1, C2, C3).  
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Similar results were obtained for myogenic responses: NS19504 at 3*10-6 M 
weakened the myogenic response, while NS19504 combined with IBTX and IBTX 
alone strengthened the myogenic response to a similar extent (Fig 3.2.8, A). 
Correspondingly, IBTX attenuated the anti-contractile effect of NS19504 (Fig 3.2.8, 
B), while NS19504 enhanced the functional availability of BK channels (Fig 3.2.8, C).  
 
The mutual complete inhibition of their respective effects indicates that IBTX and 
NS19504 (at 6*10-6 M in A.Saphena and at 3*10-6 M in A.Gracilis) can be employed 
as a selective BK channel activator and blocker, respectively.  
 
 
 
Figure 3.2.5 Original recordings of methoxamine-induced contractions in the presence of IBTX and 
NS19504 in a wire myograph experiment 
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Figure 3.2.6  Effect of NS19504 and IBTX on methoxamine-induced contractions 
A1-A3) Normalized A.Saphena tension with different methoxamine concentrations in the absence of BK channel active 
agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of NS19504 (A1: NS19504 3*10
-6
M; A2: 
NS19504 6*10
-6
M; A3: NS19504 10
-5
M) and in the combined presence of NS19504 and IBTX (NS19504 and IBTX). B1-
B3) NS19504 anti-contractile effect in the absence (Control) and presence of IBTX (IBTX 10
-7
M). C1-C3) IBTX contractile 
effect (BK channel functional availability) in the absence (Control) and presence of NS19504 (C1: NS19504 3*10
-6
M; C2: 
NS19504 6*10
-6
M; C3: NS19504 10
-5
M). n1=7; n2=7; n3=8; * - p<0.05, **- p<0.01; *** - p<0.001. 
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Figure 3.2.7 Original recordings of myogenic responses in the presence of IBTX and NS19504 in a 
pressure myograph experiment  
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Figure 3.2.8 Effect of NS19504 and IBTX on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of BK channel active 
agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of NS19504 (NS19504 3*10
-6
M) and in 
the combined presence of NS19504 and IBTX (NS19504 and IBTX). B) NS19504 anti-contractile effect in the 
absence (Control) and presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK channel functional 
availability) in the absence (Control) and presence of NS19504 (NS19504 3*10
-6
M). n=10; * - p<0.05, **- p<0.01; 
*** - p<0.001. 
 
3.2.1.3 Effect of NS19504 on arterial contractility 
Since the effect of NS19504 at 10-5M cannot be completely blocked by IBTX as 
shown in the experiments mentioned above (Fig 3.2.6), it was studied whether higher 
concentrations of NS19504 possess the ability to affect other channels, such as Kv7 
channels. 
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 Effect of NS19504 in the combined presence of IBTX and XE991 on arterial 
contractility 
In this experiment, the methoxamine-induced tension was strongly increased by the 
combination of IBTX (10-7M) and XE991 (3*10-6M) and considerably reduced by 10-
5M NS19504 alone. The combination of 10-5M NS19504 together with IBTX and 
XE991 affected the methoxamine-induced tension to a similar extent as the 
combination of XE991 and IBTX alone (Fig 3.2.9 A). Thus, in the presence of IBTX 
and XE991, NS19504 (10-5M) did not affect arterial tension. Beyond that, the 
contractile effect of IBTX together with XE991 was increased in the presence of 
NS19504 (Fig 3.2.9 B), whereas the anti-contractile effect of NS19504 was 
decreased in the presence of IBTX together with XE991 (Fig 3.2.9 C). 
Therefore, the data indicate that NS19504 at higher concentrations activates BK 
channels as well as Kv7 channels without affecting other targets.  
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Figure 3.2.9 Effect of NS19504 and IBTX together with XE991 on methoxamine-induced contractions 
A) Normalized tension of A.Saphena with different methoxamine concentrations in the absence of potassium 
channel active agents (Control), in the combined presence of IBTX with XE991 (IBTX 10
-7
M+XE991 3*10
-6
), in the 
presence of NS19504 (NS19504 10
-5
M) and in the combined presence of NS19504 and IBTX with XE991 
(NS19504+XE991+IBTX). B) IBTX with XE991 contractile effect in the absence (Control) and presence of 
NS19504 (NS19504 10
-5
M). C) NS19504 anti-contractile effect in the absence (Control) and presence of IBTX 
with XE991 (IBTX+ XE991). n=6; * - p<0.05, **- p<0.01; *** - p<0.001. 
3.2.2 Functional interaction of Kv7 channels and BK channels  
3.2.2.1 Combined effect of Kv7 channel blocker and BK channel blocker on arterial 
contractility 
After studying the respective effects of Kv7 channel active agents and BK channel 
active agents on arterial contractility, the combined effects of them were investigated 
in the subsequent experiments: 
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Firstly, the combined action of XE991 and IBTX was studied on methoxamine-
induced contractions in wire myograph and on pressure-induced myogenic 
responses in pressure myograph experiments.  
Regarding methoxamine-induced contractions, arterial tension was increased in the 
presence of IBTX at 10-7M alone or XE991 at 3*10-6M alone, and considerably 
enhanced in the presence of the combination of both XE991 and IBTX (Fig 3.1.10, 
A). Correspondingly, the functional availabilities of Kv7 channels and BK channels 
were increased in the presence of IBTX and XE991, respectively (Fig 3.1.10, B, C). 
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 Figure 3.1.10 Effect of XE991 and IBTX on methoxamine-induced contractions 
A) Normalized tension of A.Saphena with different methoxamine concentrations in the absence of potassium 
channel active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of XE991 (XE991 3*10
-6
M) 
and in the combined presence of XE991 and IBTX (XE991 + IBTX). B) XE991 contractile effect (Kv7 channel 
functional availability) in the absence (Control) and presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK 
channel functional availability) in the absence (Control) and presence of XE991 (XE991 3*10
-6
M). n=12; * - 
p<0.05, **- p<0.01; *** - p<0.001. 
When studying myogenic responses, there were two protocols employed to test the 
combined effect of IBTX and XE991: (i) IBTX was applied at first and XE991 was 
subsequently added, and (ii) XE991 was applied firstly and then IBTX was added. 
The results obtained with these two protocols were similar. The myogenic response 
was strengthened in the presence of either IBTX at 10-7M alone or XE991 at 3*10-6M 
alone. A further strengthened myogenic response was observed in the combined 
presence of IBTX and XE991 (Fig 3.2.11, A1, A2). Meanwhile, the functional 
availabilities of Kv7 channels and BK channels were enhanced markedly in the 
presence of IBTX (Fig 3.2.11 B1, B2) and XE991 (Fig 3.2.11, C1, C2), respectively. 
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 Figure 3.2.11 Effect of XE991 and IBTX on the myogenic response 
A1-A2) Normalized diameter of A.Gracilis with different intra-luminal pressures in the absence of potassium 
channel blockers (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of XE991 (XE991 3*10
-6
M) and 
in the combined presence of IBTX and XE991 (A1 in sequence XE991+ IBTX, A2 in sequence IBTX+ XE991). 
B1-B2) XE991 contractile effect (Kv7 channel functional availability) in the absence (Control) and presence of 
IBTX (IBTX 10
-7
M). C1-C2) IBTX contractile effect (BK channel functional availability) in the absence (Control) 
and presence of XE991 (XE991 3*10
-6
M). n1=10, n2=10; * - p<0.05, **- p<0.01; *** - p<0.001. 
Regarding agents selectively acting on subfamilies of Kv7 channels (Kv7.1-Kv7.5), 
there is only a selective Kv7.1 blocker, HMR1556 (Gogelein et al., 2000), available. 
Therefore, the interaction of Kv7.1 channels and BK channels was studied in the 
myogenic response by using HMR1556 and IBTX. The data show that there was no 
effect of HMR1556 at 10-5M on the myogenic response, while IBTX at 10-7M alone 
strengthened the myogenic response. The effect of the combination of IBTX and 
HMR1556 was similar to the effect of IBTX alone. Meanwhile, HMR1556 did not alter 
the functional availability of the BK channel. In turn, IBTX also did not change the 
HMR1556 contractile effect (the functional availability of Kv7.1 channels) (Fig 3.2.12). 
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 Figure 3.2.12 Effect of HMR1556 and IBTX on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of HMR1556 (HMR1556 10
-5
M) 
and in the combined presence of HMR1556 and IBTX (HMR1556 and IBTX). B) HMR1556 contractile effect in the 
absence (Control) and presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK channel functional 
availability) in the absence (Control) and presence of HMR1556 (HMR1556 10
-5
M). n=13; * - p<0.05, **- p<0.01; 
*** - p<0.001. 
3.2.2.2 Combined effect of Kv7 channel activator and BK channel activator on 
arterial contractility 
The combined action of NS19504 and retigabine was studied on methoxamine-
induced contractions in wire myograph and on pressure-induced myogenic 
responses in pressure myograph experiments. 
In methoxamine-induced contractions, NS19504 was studied at two concentrations 
(3*10-6M, 6*10-6M), both of which decreased the tension of the artery. Moreover, 
NS19504 at 6*10-6M and retigabine at 10-5M, respectively weakened arterial tension 
to a similar extent. The combined presence of NS19504 and retigabine resulted in a 
further attenuation of artery tension (Fig 3.2.13 A1, A2). At both concentrations of 
NS19504, the anti-contractile effect of NS19504 was decreased in the presence of 
retigabine (Fig 3.2.13 B1, B2) and the anti-contractile effect of retigabine was 
reduced in the presence of NS19504 (Fig 3.2.13 C1, C2).  
RESULTS 
43 
-8 -7 -6 -5
0
5 0
1 0 0
lg [M e th o x a m in e ] (M )
N
o
r
m
a
li
z
e
d
 t
e
n
s
io
n
 (
%
)
R e tig a b in e 1 0 -5 M
R e tig a b in e  +  N S 1 9 5 0 4
C o n tro l
N S 1 9 5 0 4 3 *1 0 -6 M
***
***
**
***
C o n tro l R e t ig a b in e  1 0
-5  
M
0
4 0
8 0
1 6 0
2 0 0
2 4 0
N
S
1
9
5
0
4
a
n
ti
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
* *
C o n tro l N S 1 9 5 0 4  3 *1 0
-6  
M
0
4 0
8 0
1 6 0
2 0 0
2 4 0
R
e
ti
g
a
b
in
e
a
n
ti
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
*
A 1 B 1
C 1
 
-8 -7 -6 -5
0
5 0
1 0 0
lg [M e th o x a m in e ] (M )
N
o
r
m
a
li
z
e
d
 t
e
n
s
io
n
 (
%
)
R e tig a b in e 1 0 -5 M
R e tig a b in e +  N S 1 9 5 0 4
C o n tro l
N S 1 9 5 0 4 6 *1 0 -6 M
***
***
**
*
C o n tro l R e t ig a b in e  1 0
-5
M
0
4 0
8 0
1 6 0
2 0 0
2 4 0
N
S
1
9
5
0
4
a
n
ti
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
* * *
C o n tro l N S 1 9 5 0 4  6 *1 0
-6
M
0
4 0
8 0
1 6 0
2 0 0
2 4 0
R
e
ti
g
a
b
in
e
a
n
ti
c
o
n
tr
a
c
ti
le
 e
ff
e
c
t 
(a
.u
.)
* * *
A 2 B 2
C 2
 Figure 3.2.13 Effect of retigabine and NS19504 on methoxamine-induced contractions 
A1-A2) Normalized A.Saphena tension at different methoxamine concentration in the absence of potassium 
channel active agents (Control), in the presence of retigabine (Retigabine 10
-5
M), in the presence of NS19504 (A1: 
NS19504 3*10
-6
M, A2: NS19504 6*10
-6
M) and in the combined presence of retigabine and NS19504 (Retigabine 
+ NS19504). B1-B2) NS19504 anti-contractile effect in the absence (Control) and presence of retigabine 
(Retigabine 10
-5
M). C1-C2) Retigabine anti-contractile effect in the absence (Control) and presence of NS19504 
(C1: NS19504 3*10
-6
M, C2: NS19504 6*10
-6
M). n1=11, n2=9; * - p<0.05, **- p<0.01; *** - p<0.001. 
As to the myogenic response, it was weakened respectively by NS19504 at 3*10-6M 
and retigabine at 3*10-6M. However, in the combined presence of NS19504 and 
retigabine, the myogenic response was without difference compared with that 
observed in either NS19504 alone or retigabine alone (Fig 3.2.14 A). 
Correspondingly, the anti-contractile effect of NS19504 (Fig 3.2.14 B) and the anti-
contractile effect of retigabine (Fig 3.2.14 C) are decreased in the presence of 
retigabine or NS19504, respectively. 
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 Figure 3.2.14 Effect of retigabine and NS19504 on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of retigabine (Retigabine 3*10
-6
M), in the presence of NS19504 
(NS19504 3*10
-6
M) and in the combined presence of retigabine and NS19504 (Retigabine + NS19504). B) 
NS19504 anti-contractile effect in the absence of (Control) and presence of retigabine (Retigabine 3*10
-6
M). C) 
Retigabine anti-contractile effect in the absence of (Control) and presence of NS19504 (NS19504 3*10
-6
M).  n=9; 
* - p<0.05, **- p<0.01; *** - p<0.001. 
3.2.2.3 Combined effect of Kv7 channel activator and BK channel blocker on arterial 
contractility 
The combined action of retigabine and IBTX was studied on methoxamine-induced 
contractions in wire myograph and on pressure-induced myogenic responses in 
pressure myograph experiments.  
In methoxamine-induced contractions, retigabine was studied at two concentrations 
(3*10-6M, 10-5M), both of which decreased methoxamine-induced contractions that 
were increased by IBTX at 10-7M. When IBTX was combined with retigabine at 3*10-
6M, this combination weakened arterial contraction less than retigabine at 3*10-6M 
alone, whereas the combined effect of IBTX and retigabine with 10-5M was similar to 
the effect of retigabine at 10-5M alone (Fig 3.2.15 A1, A2). In addition, in the presence 
of IBTX, the anti-contractile effect of retigabine was enhanced (Fig 3.2.15 B1, B2), 
while the functional availability of the BK channel was declined in the presence of 
retigabine at both concentrations (Fig 3.2.15 C1, C2).   
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Figure 3.2.15 Effect of retigabine and IBTX on methoxamine-induced contractions 
A1-A2) Normalized A.Saphena tension with different methoxamine concentrations in the absence of potassium 
channel active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of retigabine (A1: 
Retigabine 3*10
-6
M; A2: Retigabine 10
-5
M) and in the combined presence of retigabine and IBTX (Retigabine + 
IBTX). B1-B2) Retigabine anti-contractile effect in the absence of (Control) and presence of IBTX (IBTX 10
-7
M). 
C1-C2) IBTX contractile effect in the absence of (Control) and presence of retigabine (C1: Retigabine 3*10
-6
M, 
C2: Retigabine 10
-5
M). n1=9, n2=9; * - p<0.05, **- p<0.01; *** - p<0.001. 
In accord with the results above, retigabine at 3*10-6M weakened the myogenic 
response, while IBTX at 10-7M strengthened it. Meanwhile, the myogenic response in 
the combined presence of retigabine and IBTX was similar to that in the presence of 
retigabine alone (Fig 3.2.16 A). Correspondingly, IBTX increased the anti-contractile 
effect of retigabine (Fig 3.2.16 B), whereas retigabine attenuated the functional 
availability of BK channels (Fig3.2.16 C). 
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 Figure 3.2.16 Effect of retigabine and IBTX on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of retigabine (Retigabine 3*10
-6
M) 
and in the combined presence of retigabine and IBTX (Retigabine and IBTX). B) Retigabine anti-contractile effect 
in the absence (Control) and presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK channel functional 
availability) in the absence (Control) and presence of retigabine (Retigabine 3*10
-6
M). n=10; * - p<0.05, **- p<0.01; 
*** - p<0.001. 
3.2.2.4 Combined effect of Kv7 channel blocker and BK channel activator on arterial 
contractility 
The combined action of XE991 and NS19504 was studied on methoxamine-induced 
contractions in wire myograph and on pressure-induced myogenic responses in 
pressure myograph experiments.  
On methoxamine-induced contractions, NS19504 was studied at two concentrations 
(3*10-6M, 6*10-6M): 
At NS19504 3*10-6M, artery tension in the combination of NS19504 and XE991 was 
weaker than that in the presence of XE991 only, but stronger than that in the 
presence of NS19504 alone (Fig 3.2.17 A1). Meanwhile, there was no change in the 
anti-contractile effect of NS19504 and the functional availability of Kv7 channels in 
the presence of XE991 and NS19504, respectively (Fig 3.2.17 B1, C1).  
At NS19504 6*10-6M, artery tension in the combined presence of NS19504 and 
XE991 was similar to that in the presence of NS19504 alone (Fig 3.2.17 A2). 
Moreover, the anti-contractile effect of NS19504 was notably increased with XE991 
(Fig 3.2.17 B2), whereas the functional availability of Kv7channels was decreased 
considerably in the presence of NS19504 (Fig 3.2.17 C2).  
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 Figure 3.2.17 Effect of NS19504 and XE991 on methoxamine-induced contractions 
A1-A2) Normalized tension of A.Saphena with different methoxamine concentrations in the absence of potassium 
channel active agents (Control), in the presence of XE991 (XE991 3*10
-6
M), in the presence of NS19504 (A1: 
NS19504 3*10
-6
M; A2: NS19504 6*10
-6
M) and in the combined presence of NS19504 and XE991 (NS19504 + 
XE991). B1-B2) NS19504 anti-contractile effect in the absence (Control) and presence of XE991 (XE991 3*10
-
6
M). C1-C2) XE991 contractile effect (Kv7 channel functional availability) in the absence (Control) and presence 
of NS19504 (C1: NS19504 3*10
-6
M; C2: NS19504 6*10
-6
M). n1=11, n2=10; * - p<0.05, **- p<0.01; *** - p<0.001. 
Likewise, the myogenic response in the combined presence of NS 19504 at 3*10-6M 
and XE991 at 3*10-6M was weaker than that in the presence of XE991 alone, but 
stronger than that in the presence of NS19504 alone (Fig 3.2.18 A). There is no 
difference in the anti-contractile effect of NS19504 with or without XE991, and in the 
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functional availability of Kv7 channels with or without NS19504 (Fig 3.2.18 B, C). 
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Figure 3.2.18 Effect of NS19504 and XE991 on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of XE991 (XE991 3*10
-6
M), in the presence of NS19504 (NS19504 3*10
-
6
M) and in the combined presence of NS19504 and XE991 (NS19504 + XE991). B) NS19504 anti-contractile 
effect in the absence (Control) and presence of XE991 (XE991 3*10
-6
M). C) XE991 contractile effect (Kv7 channel 
functional availability) in the absence (Control) and presence of NS19504 (NS19504 3*10
-6
M). n=9; * - p<0.05, **- 
p<0.01; *** - p<0.001. 
 
3.2.2.5 Combined effect of BK channel blocker and non-Kv7 channel blocker on 
arterial contractility  
 Combined effect of BK channel blocker and Kv1.5 channel blocker on the 
myogenic response 
The interaction of BK channels and Kv1.5 channels in the myogenic response was 
studied by using the selective Kv1.5 channel blocker DPO-1 (Lagrutta et al., 2006) 
and IBTX. The results show that the myogenic response was strengthened in the 
respective presence of IBTX at 10-7M and of DPO-1 at 3*10-7M. The combined 
presence of IBTX and DPO-1 resulted in a further strengthening of the myogenic 
response (Fig 3.2.19 A). Correspondingly, the functional availability of Kv1.5 
channels, represented as the contractile effect of DPO-1, as well as the functional 
availability of the BK channels was increased in the presence of IBTX and DPO-1, 
respectively (Fig 3.2.19 B ,C).  
 Combined effect of BK channel blocker  and Kv2.1 channel blocker on the 
myogenic response 
The interaction of BK channels and Kv2.1 channels in the myogenic response was 
studied by application of the selective Kv2.1 channel blocker stromatoxin-1 (STTX) 
(Escoubas et al., 2002) and IBTX. The myogenic response was not strengthened in 
the presence of STTX at 10-7M. Nevertheless, the myogenic response in the 
combined presence of IBTX and STTX was stronger than that in the presence of 
STTX alone (Fig 3.2.20 A). Meanwhile, the functional availability of Kv2.1 channels, 
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expressed as the contractile effect of STTX, was increased in the presence of IBTX 
(Fig 3.2.20 B), and the functional availability of BK channels was increased in the 
presence of STTX (Fig 3.2.20C).  
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 Figure3.2.19 Effect of DPO-1 and IBTX on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of DPO-1(DPO-1 3*10
-7
M) and in 
the combined presence of DPO-1 and IBTX (DPO-1 + IBTX). B) DPO-1 contractile effect in the absence (Control) 
and presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK channel functional availability) in the absence 
(Control) and presence of DPO-1 (DPO-1 3*10
-7
M). n=11; * - p<0.05, **- p<0.01; *** - p<0.001. 
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Figure 3.2.20 Effect of STTX and IBTX on the myogenic response 
A) Normalized diameter of A.Gracilis at different intra-luminal pressures in the absence of potassium channel 
active agents (Control), in the presence of IBTX (IBTX 10
-7
M), in the presence of STTX (STTX 10
-7
M) and in the 
combined presence of STTX and IBTX (STTX + IBTX). B) STTX contractile effect in the absence (Control) and 
presence of IBTX (IBTX 10
-7
M). C) IBTX contractile effect (BK channel functional availability) in the absence 
(Control) and presence of STTX (STTX 10
-7
M). n=11; * - p<0.05, **- p<0.01; *** - p<0.001.  
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3.2.3 Summary of respective function of Kv7 channels and BK  
When combining the results of all series in this study, for methoxamine-induced 
contractions it is shown that arterial contractions are enhanced by XE991 at 
intermediate concentrations of methoxamine (3*10-7M and 10-6M), whereas they are 
weakened by retigabine at higher concentration of methoxamine (10-6M to 10-5M). On 
the other hand, IBTX enhanced arterial tension in a relatively wide range of 
methoxamine concentrations (10-7M to 3*10-6M), whereas NS19504 is similar to 
retigabine in that it also decreased contractions at higher concentrations of 
methoxamine (Table 3.2.1). 
Table 3.2.1 Effect of blockers and activators of Kv7 and BK channels on arterial contractions at different 
methoxamine concentrations in the A. Saphena 
Methoxamine 10
-8 3*10-8 10-7 3*10-7 10-6 3*10-6 10-5 n 
XE991 
3*10
-6 
p=0.65 p=0.65 p=0.15 *** *** p=0.30 p=0.65 41 
Retigabine 
10
-5
 
p> 0.99 p> 0.99 p> 0.99 p=0.14 *** *** *** 29 
IBTX 
10
-7
 
p=0.34 p=0.34 *** *** *** *** p=0.25 48 
NS19504 
3*10
-6
 p> 0.99 p> 0.99 p> 0.99 p=0.20 *** *** *** 29 
6*10
-6
 p> 0.99 p> 0.99 p= 0.98 p=0.08 *** *** *** 33 
10
-5
 p> 0.99 p> 0.99 p=0.99 p=0.84 *** *** *** 14 
* - p<0.05, **- p<0.01; *** - p<0.001 
 
Different from methoxamine-induced contractions, for pressure induced myogenic 
responses the data demonstrate that XE991 is similar to IBTX in that both enhanced 
myogenic responses at every pressure level. Retigabine as well as NS19504 
respectively reduced myogenic responses at almost every pressure levels except 
10mmHg (Table 3.2.2). 
Table 3.2.2 Effect of blockers and activators of Kv7 and BK channels on the myogenic response at 
different pressure levels in the A. Gracilis 
Pressure 10 mmHg 40 mmHg 80 mmHg 120 mmHg n 
XE991  
3*10
-6
 
p=0.05 *** *** *** 13 
Retigabine 
3*10
-6
 
(-) ** ** *** 14 
IBTX  
10
-7
 
* ** *** ** 14 
NS19504  
3*10
-6
 
(-) ** ** *** 11 
 (-)  before application of  retigabine or NS19504,  the diameter of arteries at 10mmHg was already similar to the maximum diameter in 
calcium-free solution 
* - p<0.05, **- p<0.01; *** - p<0.001 
 
3.2.4 Summary of the functional interaction of Kv7 and BK channels 
Table 3.2.3 and Table 3.2.4 show the summary of the interaction effects of different 
active agents selectively targeting Kv7 channels and BK channels. As demonstrated, 
there were several obvious interactions between these active agents, and the effects 
of interaction were similar in methoxamine-induced contractions and in myogenic 
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responses. Specifically, XE991 abolished the effect of retigabine and increased the 
effects of NS19504 and IBTX. In turn, retigabine increased the effect of XE991, and it 
impaired the effects of IBTX and NS19504. On the other hand, IBTX abolished the 
effect of NS19504, whereas it improved the effects of XE991 and retigabine. 
NS19504 increased the effect of IBTX, and reduced the effects of retigabine and 
XE991.  
Table 3.2.3 Interaction of active agents of Kv7 and BK channels in methoxamine-induced contractions 
       Effect 
Agent  
XE991 
3*10
-6
 
Retigabine 
3*10
-5
 
IBTX 
10
-7
 
NS19504 
3*10
-6  
 
6*10
-6
 
 
10
-5
 
IBTX10
-7
 
+XE 3*10
-6
 
XE991 
3*10
-6
 
 ↓*** ↑ *** p=0.84 ↑ ***   
Retigabine 
3*10
-5
 
↑ ***  ↓** ↓** ↓***   
IBTX 
10
-7
 
↑ *** ↑ **  ↓*** ↓*** ↓***  
NS19504        
3*10
-6
 p=0.85 ↓* ↑ **     
6*10
-6 
↓*** ↓*** ↑ **     
10
-5
   ↑ **    ↑ *** 
IBTX +XE 
10
-7      
3*10
-6
 
     ↓***  
* - p<0.05, **- p<0.01; *** - p<0.001 
 
Table 3.2.4 Interaction of active agents of Kv and BK channels in the myogenic response 
         Effect 
Agent 
XE991 
3*10
-6
 
Retigabine 
3*10
-6
 
IBTX 
10
-7
 
NS19504 
3*10
-6  
DPO-1 
3*10
-7
 
STTX 
10
-7
 
HMR1556 
10
-5
 
XE991 
3*10
-6
 
 ↓*** ↑ *** p=0.92    
Retigabine 
3*10
-6
 
↑ ***  ↓** ↓**    
IBTX 
10
-7
 
↑ *** ↑ **  ↓*** ↑ * ↑ ** p=0.23 
NS19504 
3*10
-6 
p=0.92 ↓** ↑ ***     
DPO-1 
3*10
-7
 
  ↑ *     
STTX 
10
-7
 
  ↑ *     
HMR1556 
10
-5
 
  p=0.24     
* - p<0.05, **- p<0.01; *** - p<0.001 
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4 DISCUSSION 
4.1 Expression of Kv7 and BK channels in rat skeletal muscle arteries 
In this study, the gene expression of Kv7 (KCNQ) and BK channels in skeletal 
muscle arteries was detected using the qPCR technique.  
According to the results, different subunits of Kv7 and BK channels are expressed in 
the A. Saphena and the A. Gracilis.  In particular, BK channels (BK α and BK β1 
subunits) are dominant as in other systemic blood vessels (Nelson and Quayle 1995; 
Tykocki et al. 2017). Regarding KCNQ genes, KCNQ4 is the most highly expressed, 
followed by KCNQ1 and KCNQ5, whose expression profile is similar to rat arteries 
studied previously (e.g. Gracilis arteries, cerebral arteries, coronary arteries, 
pulmonary arteries and mesenteric arteries) and human arteries(e.g. visceral arteries 
and mesenteric arteries) (Joshi et al., 2009; Ng et al., 2011; Zhong et al. 2010; 
Khanamiri et al. 2013; Zavaritskaya et al., 2013 ). Meanwhile, by comparison of the 
results obtained from vessel with and without endothelium, it was observed that the 
expression of Kv7 and BK channels is not dependent on the endothelium.  
Therefore, both A. Saphena and A. Gracilis can be employed to examine the function 
of Kv7 and BK channels involved in arterial contractility. To enable the study of Kv7 
and BK channels located in smooth muscle cells, vessels without endothelium can be 
used in the functional studies.  
4.2 Function of Kv7 and BK channels in rat skeletal muscle arteries 
4.2.1 Selection of appropriate methods  
As known, in vivo there are numerous physiological factors, such as 
neurotransmitters, metabolites, hormones, mechanical factors (e.g. shear stress and 
transmural pressure), and interactions between VSMCs and endothelial cells or 
between proximal and distal vessel segments, etc., participating in the regulation of 
arterial contractility. In this complex situation, it is hard to interpret experimental data 
and clarify the exact role of any ion channel involved in the modulation of arterial 
contractility (Schubert, 2005). Meanwhile, the gene expression of the potassium 
channel in A. Saphena and A. Gracilis is independent of the endothelium as 
demonstrated above. In addition, as established previously, myogenic responses and 
agonist-induced contractions are functional independent of an intact endothelium 
( Kuo et al., 1990; Falcone et al., 1991; Meininger and Davis, 1992; Gaynullina et al., 
2013). Thus, isolated arteries denuded of the endothelium were employed in this 
study. This enables us to better control the experimental conditions and to facilitate 
the interpretation of the data on the function of potassium channels involved in 
arterial contractility. 
Moreover, the intrinsic myogenic response as well as vasoactive substance 
modulation are two main mechanisms governing vascular contractility (Brozovich et 
al., 2016). Therefore, in this study, the interaction of Kv7 and BK channels in the 
regulation of the contractility of isolated arteries was examined during pressure-
induced myogenic responses (pressure myography) and agonist-induced 
contractions (wire myography) where methoxamine was used as a vasoconstrictor. 
DISCUSSION 
53 
4.2.2 Respective function of Kv7 and BK channels  
Before the discussion of the Kv7 and BK channel interaction, their respective role in 
the modulation of artery contractility will be clarified.  
In general, the data of the presented study show that Kv7 and BK channels both 
participate in the maintenance of basic vascular tone of A.Saphena and A. Gracilis 
and appear to serve as negative feedback mechanisms in pressure-induced 
myogenic responses and vasoconstrictor-induced contractions, as XE991/IBTX or 
retigabine/NS19504 enhanced or reduced arterial contractility in pressure-induced 
myogenic responses and the methoxamine-induced contractions.  
A detailed discussion of the roles of Kv7 and BK channels in the pressure-induced 
myogenic response and methoxamine-induced contraction will be presented in the 
following sections. 
4.2.2.1 Roles of Kv7 and BK channels in the myogenic response  
1) Mechanism of the myogenic response  
In the vascular system, the myogenic response is an intrinsic reaction of small 
arteries to changes in vascular intraluminal pressure, in which the artery can constrict 
further or dilate from an original partially contracted state (myogenic tone). It is 
independent of inﬂuences from neurotransmitters, metabolites, hormones, etc. and  
plays a critical role in the establishment of basic vascular tone and the autoregulation 
of blood flow in the normal blood pressure range (Bayliss 1902; Davis & Hill 1999). 
 
Although the mechanism of the myogenic response is yet to be thoroughly clarified, 
the basic mechanisms mediating this response have been demonstrated. The 
increased intraluminal pressure can cause VSMCs depolarization and an initial Ca2+ 
influx through VGCCs to activate the contractile proteins and to induce myogenic 
vasoconstriction. The pressure-induced VSMCs depolarization probably arises 
mainly from activation of mechanosensitive (MS) ion channels (e.g. nonselective 
cation channels) that allow Na+ or Ca2+ influx, stimulation of chloride channels that 
mediate Cl- efflux, and/or a possible inhibition of potassium channels.  
Besides that, pressure-induced mechanical deformation of the vascular wall can 
activate phospholipase C (PLC) and generate the second messengers inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG) to induce Ca
2+ release from the 
Figure 4.1 Example of a pressure-induced myogenic 
response in small arteries 
(Davis & Hill 1999), modified 
When the intraluminal pressure was increased 
immediately, the small artery displays a transient 
passive distension followed by vasocontriction, whereas 
when the intraluminal pressure reduced, the small artery 
shows vasodilatation following a transient collapse. 
Quantitative scales for time, pressure, and diameter 
depend on vessel type, size, species, and the method of 
study.  
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sarcoplasmic reticulum (SR)  and activate protein kinase C (PKC) thereby modulating 
the activities of potassium channels, as it occurs in the receptor-mediated activation 
process (Meininger and Davis, 1992). Meanwhile, Ca2+ release from SR and 
increased Ca2+ sensitivity (Schubert et al., 2008) also have been supposed to be 
involved in the myogenic response. 
However, pressure-induced myogenic vasoconstriction would finally arrive at a stable 
level rather than lead to progressive constriction. This is mainly ascribed to the 
activation of potassium channels by membrane depolarization, increased local Ca2+ 
or stretch itself, especially BK channels or Kv channels including Kv7 channels, 
serving as a brake on pressure-induced depolarization to limit the magnitude of the 
myogenic response(Brayden and Nelson 1992; Knot and Nelson 1995; Cole et al. 
2005; Hill et al. 2010; Zhong et al. 2010). On the other hand, increased pressure is 
also known to produce some endogenous factors that can limit the activation of 
potassium channels, such as the BK channel inhibitor 20-hydroxyeicosatrienoic acid 
(20-HETE) produced from arachidonic acid (AA) metabolism in VSMCs(Zou et al. 
1996; Davis and Hill 1999; Miyata and Roman 2005).  
2) Overview of myogenic response in present study 
In the present study, the characteristics of A.Gracilis myogenic responses to graded 
elevations of intraluminal pressure (10-120mmHg)  are in accord with the 
characteristics of typical myogenic responses, in which with an acute increase in 
intraluminal pressure, vasoconstriction was induced following a short term passive 
distension, whereas with an acute reduction in intraluminal pressure, vasodilatation 
happened following a transient collapse (Fig 4.1) (Bayliss 1902; Davis and Hill 1999).  
When the pressure increased stepwise from 40 mmHg to 80mmHg to 120 mmHg, the 
diameter of A.Gracilis at each pressure step is smaller than that at the previous, 
lower pressure step, which is consistent with the facts observed in previous 
electrophysiological experiments that with the stepwise increased pressure, a graded 
increased depolarization is recorded (Wesselman et al. 1997; Yang et al. 2009).  
3) Roles of Kv7 and BK channels in the myogenic response 
 Effect of blocker and activator of Kv7 channels on myogenic responses 
It was observed that XE991 significantly increased the A.Gracilis myogenic 
constriction at pressures greater than 10 mmHg. Correspondingly, retigabine reduced 
myogenic constriction in the similar pressure range.  
It seems that at lower pressure, Kv7 channels only weakly contribute to myogenic 
tone, which might due to the lower tension of an artery with relatively weak pressure-
induced depolarization. With the pressure increased, at 40mmHg and higher, Kv7 
channels are involved in the modulation of arterial myogenic tone. Under these 
conditions, inhibition of Kv7 channels leads to further constriction, while activation of 
Kv7 channels reduces myogenic tone.  
These data are supported by findings from other experiments showing that inhibition 
of Kv channels caused VSMCs depolarization in pressurized arterioles and 
augmented myogenic tone. For example, in rat middle cerebral arteries,  linopirdine 
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(another Kv7 channel blocker) suppressed Kv current amplitude and enhanced 
myogenic constriction at pressures ≥ 20mmHg, whereas S-1(another Kv7 channel 
activator) stimulated Kv currents and weakened myogenic responses at  pressures 
greater than 20mmHg (Zhong et al., 2010). In rabbit cerebral arteries, 4-AP (a 
general Kv1-4 channel blocker) depolarized VSMCs and augmented myogenic tone 
at pressures greater than 40 mmHg (Knot and Nelson, 1995). In rat middle cerebral 
arteries, with expression of Kv1.5 channels suppressed, the myogenic response was 
strengthened with enhanced myogenic depolarization (Chen et al., 2006).  
Therefore, the data of the present study suggest that Kv7 channels play a negative 
feedback role in the myogenic response to prevent excessive vasoconstriction by 
limiting pressure-induced depolarization. 
 Effect of blocker and activator of BK channels on myogenic responses 
Regarding BK channels, the present study showed that IBTX increased myogenic 
constriction in the pressure range from 10mmHg to 120mmHg; while NS19504 
reduced myogenic constriction in the similar pressure range, which means inhibition 
of BK channels enhances the myogenic response, while activation of BK channels 
reduces myogenic constriction.   
These findings are different from the observation in mesenteric arteries that 
demonstrated that closure of BK channels plays a major role in pressure-induced 
vasoconstriction rather than activation of BK channels  limiting the myogenic 
response(Wesselman et al., 1997; Chlopicki et al., 2001). However, our results are in 
accordance with most other findings that BK channels can be significantly activated 
in the normal pressure range, and inhibition of BK channels caused VSMCs 
depolarization and  enhanced myogenic constriction (Brayden and Nelson 1992; 
Knot and Nelson 1995; Wesselman et al. 1997; Davis and Hill 1999; Tykocki et al. 
2017). The difference to the former experiments might mainly be ascribed to the 
special experimental condition where mesenteric arteries with very weak myogenic 
tone were treated with norepinephrine producing preconstriction to enable the 
myogenic responses.   
Therefore, as with Kv7 channels, the data of the present study suggest that BK 
channels also participate in the negative feedback regulation of myogenic tone in the 
A. Gracilis 
In summary, during myogenic responses, Kv7 and BK channels can be activated 
together and function to counteract myogenic constriction by precise control of 
myogenic depolarization.  
4.2.2.2 Roles of Kv7 and BK channels in methoxamine-induced contraction  
1) Mechanism of vasoconstrictor-induced arterial contraction 
A number of vasoconstrictors, such as endothelin, angiotensin and thromboxane A2, 
can, through Gq-coupled receptors in the membrane of VSMCs, induce vascular 
contraction. Specifically, when the vasoconstrictor bind to the Gq-coupled receptors, 
PLC is activated, which generates the second messengers IP3 and DAG. IP3 can 
promote Ca2+ release from SR and the activation of MLCK to induce vasoconstriction 
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(Somlyo and Somlyo 1994; Davis and Hill, 1999; Somlyo and Somlyo 2003; 
Brozovich et al. 2016). DAG, on the other hand, can activate PKC altering the 
calcium sensitivity of the contractile apparatus and inhibiting the activities of 
potassium channels including Kv and BK channels by phosphorylation, which might 
contribute to the agonist-induced membrane depolarization and vasoconstriction 
(Fig.4.2) (Standen & Quayle 1998; Ko et al. 2008).  
 
Figure 4.2 Schematic diagram of VSMC contraction induced by vasoconstrictors 
Vasoconstrictors can, through Gq-coupled receptors in the membrane of VSMCs, activate phospholipase C (PLC), 
and generate the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 can promote 
Ca
2+ 
release from the sarcoplasmic reticulum (SR), while DAG can activate protein kinase C (PKC) to modulate 
the activities of ion channels including inhibition of Kv7 and BK channels. 
 
2) Roles of Kv7 and BK channels in methoxamine-induced arterial contraction 
In this study, methoxamine as a vasoconstrictor induced different intensity of A. 
Saphena contraction dependent on concentration.  
 Effect of blocker and activator of Kv7 channels on methoxamine-induced arterial 
contraction 
XE991 enhanced arterial contractions only at intermediate concentrations of 
methoxamine (3*10-7M and 10-6M), whereas contractions were weakened by 
retigabine at higher concentrations of methoxamine (10-6M to 10-5M). This suggests 
that at weaker contraction levels, Kv7 channels seem not to affect arterial contractility 
which might be due to the lower tension of the artery.  
With the intensity of arterial contraction increased, inhibition of Kv7 channels can 
increase arterial contractility further, while activation of Kv7 channels can reduce 
arterial contractility. Meanwhile, the data show that the concentration-response 
relationship curve for methoxamine was shifted less by XE991 than by retigabine, 
which indicates that most Kv7 channels are closed during methoxamine -induced 
contraction, and at intermediate contractions, some more Kv7 channels begin to 
open as negative feedback mechanism to arterial contraction.  
When the contraction achieved higher intensity, activation of Kv7 channels still can 
weaken arterial contractility, but inhibition of Kv7 channels cannot produce any effect 
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on arterial tension. This might be due to either almost all of the Kv7 channels have 
already been closed in order to contribute to the higher intensity of contraction 
caused by the inhibition effect of IP3 or the higher Ca2+ concentration on Kv7 
channels, or there are still some Kv7 channels open, but the further contractile effect 
induced by inhibition of them is too small compared with the already very strong 
contraction.  
Therefore, besides acting as a negative feedback, Kv7 channels might also 
contribute to promote further contraction at higher intensity level. 
 Effect of blocker and activator of BK channels on methoxamine-induced arterial 
contraction 
IBTX enhanced arterial tension in a relatively wide range of methoxamine 
concentrations (10-7M to 3*10-6M), whereas NS19504, similar to retigabine, 
decreased contractions at higher concentrations of methoxamine. 
As with Kv7 channels, BK channels do not contribute to the regulation of arterial 
tension at lower contraction levels. With enhanced contractile intensity, some BK 
channels are activated which might be due to  depolarization and an increased 
intracellular Ca2+, while some channels still keep closed. Under these conditions, 
inhibition of BK channels increases arterial contraction, while activation of BK 
channels reduces arterial tension. It is difficult to clarify which one, activated or 
closed, is the major state for BK channels during the methoxamine-induced 
contraction process. This is caused by the unspecific effect of NS19504 at higher 
concentration that hindered us to determine to what extend the methoxamine 
concentration-response curve can be really shifted when all of the BK channels are 
activated.  
At the highest intensity of contraction, activation of BK channels still can weaken 
arterial contractility, whereas inhibition of BK channels cannot produce any effect on 
arterial tension. This might due to the same possible reasons as discussed for Kv7 
channels.   
Therefore, BK channels not only play a negative feedback role in the arterial 
contraction process, but might also serve as a positive feedback to achieve highest 
intensity of contraction. 
In summary, as with pressure-induced myogenic responses, in methoxamine-induced 
contraction the activation of Kv7 and BK channels serves as a negative feedback 
modulating arterial contractility, and it seems that BK channel function is predominant 
in this process as BK channels perform negative control in a wider contractile 
intensity range. Meanwhile, the closure of Kv7 and BK channels might contribute to 
further contraction. 
4.2.3 Functional interaction of Kv7 and BK channels 
In order to investigate the interaction of Kv7 and BK channels, several combinations 
of activators and/or blockers of Kv7 and BK channels were tested as shown in the 
following table (table 4.1) in pressure-induced myogenic responses (pressure 
myography) and methoxmine-induced contractions (wire myography). 
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Table 4.1 combinations of activators and/or blockers of Kv7 and BK channels 
 Kv7 channel blocker Kv7 channel activator 
BK channel blocker  XE991+IBTX Retigabine+IBTX 
BK channel activator XE991+NS19504 Retigabine+NS19504 
 Overview of interaction between Kv7 and BK channels 
According to the results from experiments on both pressure-induced myogenic 
responses and methoxamine-induced contractions, XE991 increased the contractile 
effect of IBTX as well as the anticontractile effect of NS19504, whereas retigabine 
reduced the effect of both IBTX and NS19504. This suggested that inhibition of Kv7 
channels could increase the functional availability of BK channels, while activation of 
Kv7 channels would decrease the functional availability of BK channels.  
In turn, inhibition of BK channels can improve the functional availability of Kv7 
channels, while activation of BK channels might decrease the functional availability of 
Kv7 channels, as IBTX increased both the contractile effect of XE991 and the 
anticontractile effect of retigabine, whereas NS19504 reduced the effect of retigabine 
and to some extent impaired the effect of XE991.  
In other words, changes in the activity of Kv7 channels affect the activity of BK 
channels, and vice versa, which supports the idea that there is a dynamic equilibrium 
between the activities of Kv7 and BK channels when they perform similar function in 
regulation of arterial contractility. 
 What are the possible mechanisms underlying this dynamic equilibrium?  
This question will be discussed by focusing on Kv7 and BK channels themselves and 
essential factors of vasoconstriction (e.g. membrane potential and intracellular Ca2+). 
As mentioned in the introduction, Kv7 channels are voltage-dependent potassium (Kv) 
channels, which are directly activated by membrane depolarization. BK channels are 
large-conductance voltage-dependent and calcium-sensitive potassium channels, 
which are also activated by depolarization. Thus, membrane potential (depolarization) 
is the crucial trigger for the activation of both of these channels. In turn, their activities 
can affect the membrane potential. Especially, BK channels with large-conductance;  
activation of only a few of them would result in large changes of the membrane 
potential of VSMCs (Davis and Hill, 1999). 
However, without Ca2+, BK channels display low voltage sensitivity and are difficult to 
activate in the physiological membrane potential range. Meanwhile, there are some 
reports demonstrating that Kv channel activity can be inhibited by agonist-induced 
intracellular Ca2+ increases (Gelband et al., 1993; Ishikawa et al., 1993; Cox and 
Petrou, 1999). Therefore, intracellular Ca2+ is another key factor modulating the 
equilibrium between Kv7 and BK channels. 
Moreover, these two types of K channels belong to the potassium channel family that 
is responsible for the transport of potassium ions to the extracellular space driven by 
electrochemical potential energy. The relationship between potassium ions, the 
activities of potassium channels and the membrane potential can be described as a 
plasma membrane equivalent circuit where each type of potassium channels is in 
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parallel contributing to the total resistance of potassium channels (R) (Fig. 4.3). A 
change in the activity of any potassium channel would lead to a change in potassium 
permeability (membrane conductance, 1/R). If the concentration of potassium ions is 
almost stable, potassium permeability will become an important determinant in the 
regulation of the membrane potential.  
  
Therefore, membrane potential, intracellular calcium, and membrane permeability 
might be the three key modulators of the dynamic equilibrium between the activities 
of Kv7 and BK channels.  
In addition to the factors just mentioned, the exceeding diversity of these channels, 
arising from heteromultimerization, accessory proteins, alternate mRNA splicing or 
post-translational modification (Gutman et al., 2005), also should be taken into 
consideration. Because of channel subunit diversity, individual Kv7 or BK channels 
could possess different properties: Kv7 channels could display different voltage 
sensitivity; BK channels, besides having different voltage sensitivity, may have 
different Ca2+ sensitivity or different Ca2+ thresholds for voltage-dependent 
activation(Jackson and Blair 1998; Tykocki et al. 2017).  
In other words, Kv7 and BK channels expressed in the same artery could be 
endowed with diverse activation thresholds, which probably account for the different 
extent of activation of Kv7 and BK channels with different intensity of stimulus. 
Specifically, at a certain stimulus concentration, a certain portion of Kv7/ BK channels 
has been activated, while the other Kv7/ BK channels with higher activation 
thresholds still stay at the resting state. At this point, if the activated Kv7 channels are 
inhibited, there would be a plasma membrane depolarization and an increase of 
calcium influx through VDCCs, which can activate some resting BK channels with 
relatively low activation threshold (to increase the IBTX-induced contractile effect) 
and bring more resting BK channels to approach their activation threshold (to 
increase the NS19504-induced anticontractile effect). Likewise, inhibition of BK 
channels also causes membrane potential depolarization. This depolarization can 
directly activate a portion of resting Kv7 channels (to increase the XE991-induced 
contractile effect) and bring more resting channels to be ready for activation (to 
increase the retigabine-induced anticontractile effect). On the other hand, activation 
of Kv7/BK channels would produce membrane potential hyperpolarization and hinder 
Ca2+ influx through VDCCs, and suppress BK/Kv7 channels activities.  
In the view of the plasma membrane equivalent circuit, application of any one of the 
potassium channel blockers would reduce potassium permeability (increase 
membrane resistance). Based on this increased membrane resistance, application of 
another potassium channel blocker would produce a larger change in membrane 
potential according to Ohm’s law (U=IR).  
Figure 4.3  Equivalent circuit of the plasma 
membrane  
In the equivalent circuit of the plasma membrane, 
every type of ion channel including Kv7 and BK 
channels is in parallel and contribute to the total 
membrane conductance (g). 
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Similarly, application of any potassium channel activator increases potassium 
permeability, i.e., reduces membrane resistance. Then, when another potassium channel activator 
is applied under conditions of a reduced resistance, a smaller change in membrane 
potential will be produced. 
Therefore, it is reasonable to suggest that a dynamic equilibrium exists between Kv7 
and BK channels and contributes to the modulation of arterial contractility. However, 
it is difficult to further investigate and clarify the specific interaction of each Kv7 
subfamily with BK channels, as most of the Kv7 channel subfamilies, except Kv7.1, 
lack selective blockers/activators. The results obtained with the selective Kv7.1 
channel blocker HMR1556 in pressure-induced myogenic responses showed that 
inhibition of Kv7.1 channels did not affect vascular tone and the activity of BK 
channels, while inhibition of BK channels also did not change the activity of Kv7.1 
channels. Therefore, Kv7.1 channels appear not to participate in the maintenance of 
resting vascular tone and the regulation of myogenic responses, and these channels 
seem not to have an interaction with BK channels as well. This finding on Kv7.1 
channels is consistent with other reports showing that coronary arteries were 
contracted by pan-Kv7 blockers, whereas HMR1556 had no effect on resting 
vascular tone (Chadha et al., 2012). Furthermore, preconstricted vessels were 
relaxed by selective Kv7.2-7.5 channel activators, whereas a  Kv7.1 channel activator 
had no effect (Khanamiri et al. 2013; Tykocki et al. 2017). 
Besides Kv7 channels, other Kv channel family members also can interact with BK 
channels. In this study, it was demonstrated that inhibition of Kv1.5 channels with 
DPO-1 and inhibition of Kv2.1/4.2 channels with STTX, respectively enhanced the 
functional availability of BK channels, while inhibition of BK channels also amplified 
the functional availability of Kv1.5 and Kv2.1/4.2 channels in pressure-induced 
myogenic responses. These findings are supported by other experiments (Tsvetkov 
et al., 2016). Moreover, these findings also support the conclusion obtained on the 
Kv7/BK channel interaction. However, the specific features of the Kv1.5 and Kv2.1 
channel interaction with Kv7 channels were not further examined because they were 
out of the focus of the presented study.  
 Comprehensive interpretation of the role of Kv7 and BK channels taking into 
account their interaction 
Considering the interaction between Kv7 and BK channels, the data provided in the 
present study facilitate a more comprehensive analysis of the role of Kv7 and BK 
channels in arterial contractility.   
For example, at the lowest pressure in the myogenic responses, and on weaker 
arterial contraction in the methoxamine-induced contraction process, XE991 or IBTX 
cannot induce any contractile effect. Thus, it seems that most of Kv7 and BK 
channels keep closed and do not contribute to the lower arterial tension., However, 
based on the interaction mechanism, there might be another explanation in that 
some Kv7 or BK channels are in an open state and XE991/IBTX can inhibit them 
which should lead to a contractile effect, but this effect is completely counteracted by 
the subsequent dilatory effect resulting from the activation of BK/Kv7 channels.  
Specifically, for arteries with lower tension, application of XE991 to inhibit Kv7 
channels, on the one hand, can induce membrane depolarization and Ca2+ influx via 
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VDCCs, and hence tend to produce arterial contraction. On the other hand, it would 
simultaneously activate some resting BK channels with relatively low activation 
threshold providing hyperpolarization to counteract vasoconstriction. Hence, this 
suggests that arterial tension should be extremely increased by XE991when the 
subsequent activation of BK channels was inhibited by IBTX, even at lower arterial 
tension. And the results in this study are corresponding to this supposition. 
Application of IBTX to inhibit BK channels would produce a similar effect. In this 
process, Kv7 channels also can be simultaneously activated. Although increased 
Ca2+ might to some extent suppress the activities of Kv7 channels, the depolarization 
induced activation of Kv7 channels can overwhelmingly override this Ca2+inhibition 
effect, because the extent of the increased functional availability of Kv7 channels by 
IBTX is similar to that of BK channels enhanced by XE991. The Ca2+inhibition effect 
on Kv7 channels can be neglected.  
Corresponding to the plasma membrane equivalent circuit application of XE991would 
reduce potassium permeability (increase membrane resistance). Based on this 
increased membrane resistance, application of IBTX would produce a larger increase 
in membrane potential, and vice versa.  
Therefore, in this study, for the lower arterial tension, there is no dilatory effect 
produced by activation of Kv7 and BK channels since the artery is at a relaxed state, 
while there is no contractile effect that could either be due to the almost closed Kv7 
and BK channels at lower tension or to the effect of Kv7 and BK channel interaction 
in which the effect of subsequent BK/Kv7activation completely counteracts the 
original Kv7/BK inhibition. 
4.2.4 Effect of the novel BK channel opener NS19504 
The results presented in this study not only demonstrated the interaction of Kv7 and 
BK channels, but also provided new information on the novel BK channel opener 
NS19504 (Nausch et al., 2014). According to the results, it is important to note that 
the selectivity of NS19504 on BK channels is concentration dependent. 
Firstly, the effect of NS19504 at higher concentrations (10-5M) cannot be completely 
blocked by IBTX alone during methoxamine-induced contractions, but it can be 
completely blocked by IBTX combined with XE991, which indicated that NS19504 at 
higher concentrations not only potently activates BK channels but simultaneously 
stimulates Kv7 channels as well. 
For the lower concentration of NS19504 (3*10-6M), during pressure-induced 
myogenic responses and methoxamine-induced contractions, its effect seemed to be 
completely blocked by IBTX, but the effect is relative too weak to clearly clarify its 
interaction with Kv7 channel active agents.  
Fortunately, NS19504 at 6*10-6M performed as a highly selective activator of BK 
channels, because the effect of NS19504 at this concentration can be completely 
blocked by IBTX. In addition, it decreased the respective effect of retigabine and 
XE991; in turn, XE991 enhanced its effect. Unfortunately, this concentration of 
NS19504 could not be tested on the myogenic response, because of the danger to 
loose myogenic reactivity. 
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Therefore, in this study, NS19504 at 6*10-6M can selectively activate BK channels, 
and definitely reduces the anticontractile effect of retigabine as well as the contractile 
effect of XE991, although NS19504 at higher concentrations seems to activate BK 
channels as well as some Kv7 channels. These results provide valuable information 
to direct us how to choose a selective concentration of NS19504 for the BK channel 
and how to analyze related results in a more objective and comprehensive way.  
4.3 Conclusion  
Kv7 channels and BK channels are expressed in rat skeletal muscle arteries, the A. 
Saphena and the A.Gracilis. They mainly function as a negative feedback in the 
regulation of the contractility of these arteries. Moreover, there is a dynamic 
equilibrium between Kv7 and BK channels, in which, membrane potential, 
concentration of Ca2+, and membrane permeability might be the three major factors 
to build a bridge between Kv7 and BK channels.  
Regarding NS19504, the selectivity of NS19504 for BK channels is concentration 
dependent. At 6*10-6 M NS19504 predominantly activates BK channels, whereas at 
higher concentrations, NS19504 is able to activate Kv7 channels as well.  
4.4 Outlook 
In this study, we have demonstrated for the first time that there is functional 
interaction between Kv7 and BK channels. However, we were unable to further clarify 
the respective roles of Kv7 subfamily members in this interaction process, because of 
a lack of corresponding selective blockers/activators, except for Kv7.1 channels that 
did not interact with BK channels. Meanwhile, it is a little bit unfortunate that 
NS19504 in this study was not able to activate BK channels completely with very 
satisfied high selectivity. Thus, the highest selective concentration used probably did 
not activate all BK channels so that we could not determine how vessel contractility 
alters under a full activation of BK channels. Therefore, exploitation and development 
of highly effective and selective blockers/activators of specific potassium channels is 
still very important for the thorough investigation of potassium channel function and 
their interaction. Moreover, with genetic techniques development, such as gene 
knockout or knockdown, siRNA interference etc., intervention with potassium channel 
expression has become another promising way to investigate the roles of specific 
potassium channels and their interaction. These genetic methods also can 
completely avoid the influence of interaction of active channel agents, although there 
is no report demonstrated there is obvious direct interaction between the activators 
and blockers employed in this study. The only limitation of this approach at the 
moment is that vessels have to be cultured for this purpose, but culture itself might 
induce changes in potassium channel expression. 
Besides functional experiments, electrophysiological studies would directly provide 
more specific information on how membrane potential and potassium permeability 
changes during the interaction of Kv7 and BK channels. This electrophysiological 
information would provide helpful and forceful clues to further confirm and clarify the 
mechanism underlying this interaction. However, due to the large amount of 
experiments required for this approach, these were beyond the focus of the 
presented study.  
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Meanwhile, it is a promising direction to further investigate and clarify the possible 
factors involved in the modulation of the equilibrium between Kv7 and BK channels, 
especially the role of other ion channels, intracellular signaling molecules, such as 
second messengers (PKA, PKG and PKC) etc. However, a successful investigation 
in this direction depends on the effective intervention on the candidate factors.   
In addition to physiological conditions, it is also worth to investigate how the 
equilibrium of Kv7 and BK channels changes in vascular diseases, which might 
provide some valuable indications to improve and innovate relevant intervention and 
treatment. It has been demonstrated that Kv7 and BK channels, respectively 
participate in several vascular pathophysiological process. But how they are exactly 
changed is still controversial. For example, in hypertension, expression and function 
of Kv7.4 channels are decreased in mesenteric arteries and coronary arteries(Jepps 
et al. 2011; Khanamiri et al. 2013), whereas it seems not to be altered in the gracilis 
arteries(Zavaritskaya et al., 2013); BK channel expression and function also have 
been reported to be enhanced as well as reduced in resistance arteries and 
arterioles(Tykocki et al., 2017). These controversial findings make the effect of a 
targeted therapy on single specific ion channels uncertain. It might be a promising 
breakthrough point for therapy to regulate the equilibrium between Kv7 and BK 
channels. However, till now, there are no studies to investigate this area. In the future, 
electrophysiological studies and functional studies combined with genetic techniques 
might facilitate a clear description and intervention of the changes in Kv7 and BK 
channel interaction in vascular diseases. 
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5 SUMMARY 
The cardiovascular system is an organ system comprising three basic parts: heart, 
blood and vessels. Among them, the contractility of vessels plays an essential role in 
the determination of blood pressure and the regulation of blood distribution to 
different organs and tissues in order to meet the demand of the body. Membrane 
potential is one major determinant of vascular contractility, as the increased Ca2+ 
influx to trigger vascular contractile activity is mainly from the extracellular space 
through voltage-dependent Ca2+ channels. 
Voltage-gated potassium (Kv) channels and large-conductance calcium-sensitive 
potassium (BK) channels are two major potassium channels identified in vascular 
smooth muscle cells, which provide hyperpolarizing conductance that contributes to 
the determination of membrane potential and Ca2+ influx, and hence play an 
important role in regulation of vascular contractility. Although they have become the 
spotlight of investigation in recent years there are only a few reports describing their 
expression and function in skeletal muscle arteries. Moreover, there is no report to 
clarify whether there is functional interaction of Kv7 and BK channels in intact 
arteries. Therefore, this study addressed the hypothesis that there is functional 
interaction between Kv7 and BK channels in skeletal muscle arteries under normal 
physiological conditions, which contributes to the maintenance of arterial contractility. 
The Saphenous artery (A. Saphena, a conduit artery supplying blood to a large part 
of skeletal muscles on the hind limb) and the Gracilis artery (A. Gracilis, a resistance 
artery providing blood to the gracilis muscle on the hind limb) from Wistar rats (male, 
8-12 weeks old) were isolated for this study. The expression of Kv7 and BK channels 
was detected by use of the qPCR technique; the function of Kv7 and BK channels 
and their interaction were examined on the A. Saphena during methoxamine-induced 
contractions using wire myography and on the A. Gracilis during pressure-induced 
myogenic responses using pressure myography. 
The results show that several subfamily members of Kv7 channels (KCNQ) and BK 
channels were expressed in A. Saphena and A. Gracilis: the highest expression was 
observed for BKα, BKβ1 and KCNQ4, followed by KCNQ1, the other subfamily 
members were found at lower expression levels. Moreover, their expression was 
independent of the endothelium. In methoxamine-induced contractions and pressure-
induced myogenic responses, inhibition of Kv7 channels or BK channels by XE991 (a 
selective blocker of Kv7 channels) or IBTX (a selective blocker of BK channels) 
enhanced arterial contractility, whereas activation of Kv7 channels or BK channels by 
retigabine (a selective activator of Kv7 channels) or NS19504 (a novel activator of BK 
channels) reduced arterial contractility. Furthermore, XE991 increased the contractile 
effect of IBTX as well as the anticontractile effect of NS19504, whereas retigabine 
reduced the effect of both IBTX and NS19504, which suggests that inhibition of Kv7 
channels increases the functional availability of BK channels, while activation of Kv7 
channels decreases the functional availability of BK channels. In turn, IBTX increased 
both the contractile effect of XE991 and the anticontractile effect of retigabine, 
whereas NS19504 reduced the effect of retigabine and impaired the effect of XE991, 
which indicates that inhibition of BK channels improves the functional availability of 
Kv7 channels, while activation of BK channels decreases the functional availability of 
Kv7 channels.  
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In conclusion, Kv7 and BK channels are expressed in rat skeletal muscle arteries and 
function as negative feedback modulators in the regulation of contractility of these 
arteries. Moreover, there is a dynamic equilibrium between Kv7 and BK channels, in 
which, membrane potential, concentration of Ca2+, and membrane permeability might 
be the three major factors to build a bridge between Kv7 and BK channels.  
In the future, functional studies and electrophysiological studies combined with 
genetic techniques might facilitate further clarification of the mechanism underlying 
Kv7 and BK channel interaction and might provide a promising direction in the 
treatment of relevant vascular diseases. 
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